<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36555161</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>24</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>08</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Sensory Involvement in Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">15521</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms232415521</ELocationID><Abstract><AbstractText>Although amyotrophic lateral sclerosis (ALS) is pre-eminently a motor disease, the existence of non-motor manifestations, including sensory involvement, has been described in the last few years. Although from a clinical perspective, sensory symptoms are overshadowed by their motor manifestations, this does not mean that their pathological significance is not relevant. In this review, we have made an extensive description of the involvement of sensory and autonomic systems described to date in ALS, from clinical, neurophysiological, neuroimaging, neuropathological, functional, and molecular perspectives.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rubio</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-0735-6854</Identifier><AffiliationInfo><Affiliation>Neuromuscular Unit, Department of Neurology, Hospital del Mar, 08003 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences and CIBERNED, Universitat Aut&#xf2;noma de Barcelona, 08193 Bellaterra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Herrando-Grabulosa</LastName><ForeName>Mireia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences and CIBERNED, Universitat Aut&#xf2;noma de Barcelona, 08193 Bellaterra, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9849-902X</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences and CIBERNED, Universitat Aut&#xf2;noma de Barcelona, 08193 Bellaterra, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>RTI2018-096386-B-I00</GrantID><Agency>Instituto de Salud Carlos III</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059906" MajorTopicYN="N">Neuroimaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001341" MajorTopicYN="N">Autonomic Nervous System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">autonomic</Keyword><Keyword MajorTopicYN="N">proprioceptive</Keyword><Keyword MajorTopicYN="N">sensory</Keyword><Keyword MajorTopicYN="N">small fiber</Keyword><Keyword MajorTopicYN="N">somatosensory</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>23</Day><Hour>1</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36555161</ArticleId><ArticleId IdType="pmc">PMC9779879</ArticleId><ArticleId IdType="doi">10.3390/ijms232415521</ArticleId><ArticleId IdType="pii">ijms232415521</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McCombe P.A., Wray N.R., Henderson R.D. Extra-motor abnormalities in amyotrophic lateral sclerosis: Another layer of heterogeneity. Expert Rev. Neurother. 2017;17:561&#x2013;577. doi: 10.1080/14737175.2017.1273772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2017.1273772</ArticleId><ArticleId IdType="pubmed">27983884</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao Q.Q., Wei Q., Wu Z.Y. Sensory nerve disturbance in amyotrophic lateral sclerosis. Life Sci. 2018;203:242&#x2013;245. doi: 10.1016/j.lfs.2018.04.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2018.04.052</ArticleId><ArticleId IdType="pubmed">29709651</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot J.M., Joffroy A. Deux cas d&#x2019;atrophie musculaire progressive: Avec lesions de la substance grise et des fiasceaux ant&#xe9;rolatet&#xe9;raux de la moell &#xe9;pini&#xe8;re. Arch. Physiol. Norm. Path. 1869;2:744&#x2013;760.</Citation></Reference><Reference><Citation>Brooks B.R., Miller R.G., Swash M., Munsat T.L., World Federation of Neurology Research Group on Motor Neuron Diseases El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:293&#x2013;299. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial &#x201c;Clinical limits of amyotrophic lateral sclerosis&#x201d; workshop contributors. J. Neurol. Sci. 1994;124:96&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pubmed">7807156</ArticleId></ArticleIdList></Reference><Reference><Citation>de Carvalho M., Dengler R., Eisen A., England J.D., Kaji R., Kimura J., Mills K., Mitsumoto H., Nodera H., Shefner J., et al. Electrodiagnostic criteria for diagnosis of ALS. Clin. Neurophysiol. 2008;119:497&#x2013;503. doi: 10.1016/j.clinph.2007.09.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2007.09.143</ArticleId><ArticleId IdType="pubmed">18164242</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Swash M. The expanding syndrome of amyotrophic lateral sclerosis: A clinical and molecular odyssey. J. Neurol. Neurosurg. Psychiatry. 2015;86:667&#x2013;673. doi: 10.1136/jnnp-2014-308946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308946</ArticleId><ArticleId IdType="pmc">PMC4453495</ArticleId><ArticleId IdType="pubmed">25644224</ArticleId></ArticleIdList></Reference><Reference><Citation>McCluskey L., Vandriel S., Elman L., Van Deerlin V.M., Powers J., Boller A., Wood E.M., Woo J., McMillan C.T., Rascovsky K., et al. ALS-Plus syndrome: Non-pyramidal features in a large ALS cohort. J. Neurol. Sci. 2014;345:118&#x2013;124. doi: 10.1016/j.jns.2014.07.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2014.07.022</ArticleId><ArticleId IdType="pmc">PMC4177937</ArticleId><ArticleId IdType="pubmed">25086858</ArticleId></ArticleIdList></Reference><Reference><Citation>Fullmer H.M., Siedler H.D., Krooth R.S., Kurland L.T. A cutaneous disorder of connective tissue in amyotrophic lateral sclerosis. A histochemical study. Neurology. 1960;10:717&#x2013;724. doi: 10.1212/WNL.10.8.717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.10.8.717</ArticleId><ArticleId IdType="pubmed">13825623</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Yamada K., Ono S., Ishibashi Y. Skin changes in patients with amyotrophic lateral sclerosis: Light and electron microscopic observations. J. Am. Acad. Dermatol. 1987;17:1006&#x2013;1012. doi: 10.1016/S0190-9622(87)70290-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0190-9622(87)70290-4</ArticleId><ArticleId IdType="pubmed">2963035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S., Toyokura Y., Mannen T., Ishibashi Y. &#x201c;Delayed return phenomenon&#x201d; in amyotrophic lateral sclerosis. Acta Neurol. Scand. 1988;77:102&#x2013;107. doi: 10.1111/j.1600-0404.1988.tb05879.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1988.tb05879.x</ArticleId><ArticleId IdType="pubmed">2856847</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa T., Toyokura Y. Letter: Amyotrophic lateral sclerosis and bedsores. Lancet. 1976;1:862. doi: 10.1016/S0140-6736(76)90517-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(76)90517-1</ArticleId><ArticleId IdType="pubmed">56680</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S., Toyokura Y., Mannen T., Ishibashi Y. Amyotrophic lateral sclerosis: Histologic, histochemical, and ultrastructural abnormalities of skin. Neurology. 1986;36:948&#x2013;956. doi: 10.1212/WNL.36.7.948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.36.7.948</ArticleId><ArticleId IdType="pubmed">3714056</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono S. The skin in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2000;1:191&#x2013;199. doi: 10.1080/14660820050515188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820050515188</ArticleId><ArticleId IdType="pubmed">11464952</ArticleId></ArticleIdList></Reference><Reference><Citation>Par&#xe9; B., Gros-Louis F. Potential skin involvement in ALS: Revisiting Charcot&#x2019;s observation&#x2014;A review of skin abnormalities in ALS. Rev. Neurosci. 2017;28:551&#x2013;572. doi: 10.1515/revneuro-2017-0004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2017-0004</ArticleId><ArticleId IdType="pubmed">28343168</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E., Raaphorst J., Klein Twennaar M., de Visser M., Schmand B.A., de Haan R.J. The cognitive profile of ALS: A systematic review and meta-analysis update. J. Neurol. Neurosurg. Psychiatry. 2016;87:611&#x2013;619. doi: 10.1136/jnnp-2015-310734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310734</ArticleId><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Phukan J., Elamin M., Bede P., Jordan N., Gallagher L., Byrne S., Lynch C., Pender N., Hardiman O. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. J. Neurol. Neurosurg. Psychiatry. 2012;83:102&#x2013;108. doi: 10.1136/jnnp-2011-300188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-300188</ArticleId><ArticleId IdType="pubmed">21836033</ArticleId></ArticleIdList></Reference><Reference><Citation>Montuschi A., Iazzolino B., Calvo A., Moglia C., Lopiano L., Restagno G., Brunetti M., Ossola I., Presti A.L., Cammarosano S., et al. Cognitive correlates in amyotrophic lateral sclerosis: A population-based study in Italy. J. Neurol. Neurosurg. Psychiatry. 2015;86:168&#x2013;173. doi: 10.1136/jnnp-2013-307223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307223</ArticleId><ArticleId IdType="pubmed">24769471</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Z., Alruwaili A.R.S., Henderson R.D., McCombe P.A. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival. J. Neurol. Sci. 2017;376:16&#x2013;23. doi: 10.1016/j.jns.2017.02.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.02.061</ArticleId><ArticleId IdType="pubmed">28431606</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C. Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement. Geriatr. Cogn. Disord. 2004;17:337&#x2013;341. doi: 10.1159/000077167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000077167</ArticleId><ArticleId IdType="pubmed">15178949</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., van Swieten J.C., Seelaar H., Dopper E.G., Onyike C.U., et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Pt 9Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M., Phukan J., Bede P., Jordan N., Byrne S., Pender N., Hardiman O. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology. 2011;76:1263&#x2013;1269. doi: 10.1212/WNL.0b013e318214359f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318214359f</ArticleId><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H.-J., Debray T.P.A., Visser A.E., van Eijk R.P.A., Rooney J.P.K., Calvo A., Martin S., McDermott C.J., Thompson A.G., Pinto S., et al. Prognosis for patients with amyotrophic lateral sclerosis: Development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433. doi: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S., Leigh P.N., Harvey A., Vythelingum G.N., Gris&#xe9; D., Goldstein L.H. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS) Neuropsychologia. 2000;38:734&#x2013;747. doi: 10.1016/S0028-3932(99)00146-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0028-3932(99)00146-3</ArticleId><ArticleId IdType="pubmed">10689049</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans J., Olm C., McCluskey L., Elman L., Boller A., Moran E., Rascovsky K., Bisbing T., McMillan C., Grossman M. Impaired cognitive flexibility in amyotrophic lateral sclerosis. Cogn. Behav. Neurol. 2015;28:17&#x2013;26. doi: 10.1097/WNN.0000000000000049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNN.0000000000000049</ArticleId><ArticleId IdType="pmc">PMC4375966</ArticleId><ArticleId IdType="pubmed">25812127</ArticleId></ArticleIdList></Reference><Reference><Citation>Stukovnik V., Zidar J., Podnar S., Repovs G. Amyotrophic lateral sclerosis patients show executive impairments on standard neuropsychological measures and an ecologically valid motor-free test of executive functions. J. Clin. Exp. Neuropsychol. 2010;32:1095&#x2013;1109. doi: 10.1080/13803391003749236.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13803391003749236</ArticleId><ArticleId IdType="pubmed">20582796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash S., Olm C., McMillan C., Boller A., Irwin D., McCluskey L., Elman L., Grossman M. Deficits in sentence expression in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2015;16:31&#x2013;39. doi: 10.3109/21678421.2014.974617.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.974617</ArticleId><ArticleId IdType="pmc">PMC4372458</ArticleId><ArticleId IdType="pubmed">25482157</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash S., Menaged A., Olm C., McMillan C., Boller A., Irwin D., McCluskey L., Elman L., Grossman M. Narrative discourse deficits in amyotrophic lateral sclerosis. Neurology. 2014;83:520&#x2013;528. doi: 10.1212/WNL.0000000000000670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000670</ArticleId><ArticleId IdType="pmc">PMC4142005</ArticleId><ArticleId IdType="pubmed">24991038</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambini V., Arcara G., Martinelli I., Bernini S., Alvisi E., Moro A., Cappa S.F., Ceroni M. Communication and pragmatic breakdowns in amyotrophic lateral sclerosis patients. Brain Lang. 2016;153&#x2013;154:1&#x2013;12. doi: 10.1016/j.bandl.2015.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bandl.2015.12.002</ArticleId><ArticleId IdType="pubmed">26799425</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley S.C., Rush B.K. Considerations for clinical neuropsychological evaluation in amyotrophic lateral sclerosis. Arch. Clin. Neuropsychol. 2017;32:906&#x2013;916. doi: 10.1093/arclin/acx089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/arclin/acx089</ArticleId><ArticleId IdType="pubmed">29028904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P., Mioshi E., Zoing M.C., Kiernan M.C., Hodges J.R. How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph. Lateral Scler. 2011;12:45&#x2013;51. doi: 10.3109/17482968.2010.520718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.520718</ArticleId><ArticleId IdType="pubmed">20849323</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T., Pinto-Grau M., Lonergan K., Bede P., O&#x2019;Sullivan M., Heverin M., Vajda A., McLaughlin R.L., Pender N., Hardiman O. A Cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: Subphenotypes, staging, cognitive predictors, and survival. Ann. Clin. Transl. Neurol. 2017;4:305&#x2013;317. doi: 10.1002/acn3.407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.407</ArticleId><ArticleId IdType="pmc">PMC5420811</ArticleId><ArticleId IdType="pubmed">28491898</ArticleId></ArticleIdList></Reference><Reference><Citation>Borrego-&#xc9;cija S., Turon-Sans J., Ximelis T., Aldecoa I., Molina-Porcel L., Povedano M., Rubio M.A., G&#xe1;mez J., Cano A., Par&#xe9;-Curell M., et al. Cognitive decline in amyotrophic lateral sclerosis: Neuropathological substrate and genetic determinants. Brain Pathol. 2021;31:e12942. doi: 10.1111/bpa.12942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12942</ArticleId><ArticleId IdType="pmc">PMC8412113</ArticleId><ArticleId IdType="pubmed">33576076</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorges M., Vercruysse P., M&#xfc;ller H.-P., Huppertz H.-J., Rosenbohm A., Nagel G., Weydt P., Peters&#xe9;n &#xc5;., Ludolph A.C., Kassubek J., et al. Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:1033&#x2013;1041. doi: 10.1136/jnnp-2017-315795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315795</ArticleId><ArticleId IdType="pubmed">28596251</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F., Karavasilis E., Riederer F., Zalonis I., Ferentinos P., Velonakis G., Xirou S., Rentzos M., Argiropoulos G., Zouvelou V., et al. Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis. Brain Imaging Behav. 2018;12:547&#x2013;563. doi: 10.1007/s11682-017-9722-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-017-9722-y</ArticleId><ArticleId IdType="pubmed">28425061</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J., Atsuta N., Watanabe H., Bagarinao E., Imai K., Yokoi D., Riku Y., Masuda M., Nakamura R., Watanabe H., et al. Structural MRI correlates of amyotrophic lateral sclerosis progression. J. Neurol. Neurosurg. Psychiatry. 2017;88:901&#x2013;907. doi: 10.1136/jnnp-2016-314337.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314337</ArticleId><ArticleId IdType="pubmed">28501822</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu S., Menke R.A.L., Talbot K., Kiernan M.C., Turner M.R. Regional thalamic MRI as a marker of widespread cortical pathology and progressive frontotemporal involvement in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2018;89:1250&#x2013;1258. doi: 10.1136/jnnp-2018-318625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318625</ArticleId><ArticleId IdType="pubmed">30049750</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P., Omer T., Finegan E., Chipika R.H., Iyer P.M., Doherty M.A., Vajda A., Pender N., McLaughlin R.L., Hutchinson S., et al. Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: A multimodal neuroimaging study. Brain Imaging Behav. 2018;12:1696&#x2013;1707. doi: 10.1007/s11682-018-9837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-9837-9</ArticleId><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.-F., Bruneteau G., Munerati E., Salachas F., Le Forestier N., Lacomblez L., Lenglet T., Meininger V. Extrapyramidal stiffness in patients with amyotrophic lateral sclerosis. Mov. Disord. 2009;24:2143&#x2013;2148. doi: 10.1002/mds.22762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22762</ArticleId><ArticleId IdType="pubmed">19735090</ArticleId></ArticleIdList></Reference><Reference><Citation>Waring S.C., Esteban-Santillan C., Reed D.M., Craig U.K., Labarthe D.R., Petersen R.C., Kurland L.T. Incidence of amyotrophic lateral sclerosis and of the parkinsonism-dementia complex of Guam, 1950&#x2013;1989. Neuroepidemiology. 2004;23:192&#x2013;200. doi: 10.1159/000078505.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000078505</ArticleId><ArticleId IdType="pubmed">15272222</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris G., Borghero G., Cannas A., Di Stefano F., Costantino E., Murru M.R., Brunetti M., Restagno G., Traynor B.J., Marrosu M.G., et al. Frontotemporal dementia with psychosis, parkinsonism, visuo-spatial dysfunction, upper motor neuron involvement associated to expansion of C9ORF72: A peculiar phenotype? J. Neurol. 2012;259:1749&#x2013;1751. doi: 10.1007/s00415-012-6444-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-012-6444-3</ArticleId><ArticleId IdType="pmc">PMC4164047</ArticleId><ArticleId IdType="pubmed">22323211</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilke C., Pomper J.K., Biskup S., Pusk&#xe1;s C., Berg D., Synofzik M. Atypical parkinsonism in C9orf72 expansions: A case report and systematic review of 45 cases from the literature. J. Neurol. 2016;263:558&#x2013;574. doi: 10.1007/s00415-016-8021-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-016-8021-7</ArticleId><ArticleId IdType="pubmed">26810719</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindquist S.G., Duno M., Batbayli M., Puschmann A., Braendgaard H., Mardosiene S., Svenstrup K., Pinborg L.H., Vestergaard K., Hjermind L.E., et al. Corticobasal and ataxia syndromes widen the spectrum of C9ORF72 hexanucleotide expansion disease. Clin. Genet. 2013;83:279&#x2013;283. doi: 10.1111/j.1399-0004.2012.01903.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2012.01903.x</ArticleId><ArticleId IdType="pubmed">22650353</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G., Floris G., Cannas A., Marrosu M.G., Murru M.R., Costantino E., Parish L.D., Pugliatti M., Ticca A., Traynor B.J., et al. A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD. Neurobiol. Aging. 2011;32:2327.e1&#x2013;2327.e5. doi: 10.1016/j.neurobiolaging.2011.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.06.009</ArticleId><ArticleId IdType="pmc">PMC3192246</ArticleId><ArticleId IdType="pubmed">21803454</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattante S., Millecamps S., Stevanin G., Rivaud-P&#xe9;choux S., Moigneu C., Camuzat A., Da Barroca S., Mundwiller E., Couarch P., Salachas F., et al. Contribution of ATXN2 intermediary polyQ expansions in a spectrum of neurodegenerative disorders. Neurology. 2014;83:990&#x2013;995. doi: 10.1212/WNL.0000000000000778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000778</ArticleId><ArticleId IdType="pmc">PMC4162303</ArticleId><ArticleId IdType="pubmed">25098532</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproviero W., Shatunov A., Stahl D., Shoai M., van Rheenen W., Jones A.R., Al-Sarraj S., Andersen P.M., Bonini N.M., Conforti F.L., et al. ATXN2 trinucleotide repeat length correlates with risk of ALS. Neurobiol. Aging. 2017;51:178.e1&#x2013;178.e9. doi: 10.1016/j.neurobiolaging.2016.11.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.11.010</ArticleId><ArticleId IdType="pmc">PMC5302215</ArticleId><ArticleId IdType="pubmed">28017481</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe R., Higashi S., Nonaka T., Kawakami I., Oshima K., Niizato K., Akiyama H., Yoshida M., Hasegawa M., Arai T. Intracellular dynamics of Ataxin-2 in the human brains with normal and frontotemporal lobar degeneration with TDP-43 inclusions. Acta Neuropathol. Commun. 2020;8:176. doi: 10.1186/s40478-020-01055-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01055-9</ArticleId><ArticleId IdType="pmc">PMC7594343</ArticleId><ArticleId IdType="pubmed">33115537</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker L.A., Huang B., Bieri G., Ma R., Knowles D.A., Jafar-Nejad P., Messing J., Kim H.J., Soriano A., Auburger G., et al. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice. Nature. 2017;544:367&#x2013;371. doi: 10.1038/nature22038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22038</ArticleId><ArticleId IdType="pmc">PMC5642042</ArticleId><ArticleId IdType="pubmed">28405022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart M.P., Gitler A.D. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications. J. Neurosci. 2012;32:9133&#x2013;9142. doi: 10.1523/JNEUROSCI.0996-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0996-12.2012</ArticleId><ArticleId IdType="pmc">PMC3418890</ArticleId><ArticleId IdType="pubmed">22764223</ArticleId></ArticleIdList></Reference><Reference><Citation>Coco D.L., Puligheddu M., Mattaliano P., Congiu P., Borghero G., Fantini M.L., La Bella V., Ferri R. REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol. Scand. 2017;135:219&#x2013;224. doi: 10.1111/ane.12593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12593</ArticleId><ArticleId IdType="pubmed">27027974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebben M.R., Shahbazi M., Lange D.J., Krieger A.C. REM behavior disorder associated with familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:473&#x2013;474. doi: 10.3109/17482968.2012.673172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.673172</ArticleId><ArticleId IdType="pubmed">22670878</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanjak M., Hirsch M.A., Bravver E.K., Bockenek W.L., Norton H.J., Brooks B.R. Vestibular deficits leading to disequilibrium and falls in ambulatory amyotrophic lateral sclerosis. Arch. Phys. Med. Rehabil. 2014;95:1933&#x2013;1939. doi: 10.1016/j.apmr.2014.05.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2014.05.024</ArticleId><ArticleId IdType="pubmed">24946083</ArticleId></ArticleIdList></Reference><Reference><Citation>De Carvalho M., Turkman A., Swash M. Sensory modulation of fasciculation discharge frequency. Muscle Nerve. 2019;59:688&#x2013;693. doi: 10.1002/mus.26456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26456</ArticleId><ArticleId IdType="pubmed">30809821</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika R.H., Mulkerrin G., Murad A., Lope J., Hardiman O., Bede P. Alterations in somatosensory, visual and auditory pathways in amyotrophic lateral sclerosis: An under-recognised facet of ALS. J. Integr. Neurosci. 2022;21:88. doi: 10.31083/j.jin2103088.</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103088</ArticleId><ArticleId IdType="pubmed">35633169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mezzapesa D.M., D&#x2019;Errico E., Tortelli R., Distaso E., Cortese R., Tursi M., Federico F., Zoccolella S., Logroscino G., Dicuonzo F., et al. Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis. PLoS ONE. 2013;8:e80748. doi: 10.1371/journal.pone.0080748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0080748</ArticleId><ArticleId IdType="pmc">PMC3835750</ArticleId><ArticleId IdType="pubmed">24278317</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E., Lillo P., Yew B., Hsieh S., Savage S., Hodges J.R., Kiernan M.C., Hornberger M. Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology. 2013;80:1117&#x2013;1123. doi: 10.1212/WNL.0b013e31828869da.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31828869da</ArticleId><ArticleId IdType="pubmed">23427327</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C., Kasper E., Dyrba M., Machts J., Bittner D., Kaufmann J., Mitchell A.J., Benecke R., Teipel S., Vielhaber S., et al. Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiol. Aging. 2014;35:240&#x2013;246. doi: 10.1016/j.neurobiolaging.2013.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.07.020</ArticleId><ArticleId IdType="pubmed">23992619</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli E.G., Agosta F., Ferraro P.M., Riva N., Lunetta C., Falzone Y.M., Comi G., Falini A., Filippi M. Brain MR imaging in patients with lower motor neuron-predominant disease. Radiology. 2016;280:545&#x2013;556. doi: 10.1148/radiol.2016151846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2016151846</ArticleId><ArticleId IdType="pubmed">26963576</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F., Karavasilis E., Velonakis G., Rentzos M., Zambelis T., Zouvelou V., Xirou S., Ferentinos P., Efstathopoulos E., Kelekis N., et al. Motor and extra-motor gray matter integrity may underlie neurophysiologic parameters of motor function in amyotrophic lateral sclerosis: A combined voxel-based morphometry and transcranial stimulation study. Brain Imaging Behav. 2018;12:1730&#x2013;1741. doi: 10.1007/s11682-018-9841-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-9841-0</ArticleId><ArticleId IdType="pubmed">29417490</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V., Pioro E.P. Corticospinal tract and related grey matter morphometric shape analysis in ALS phenotypes: A fractal dimension study. Brain Sci. 2021;11:371. doi: 10.3390/brainsci11030371.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030371</ArticleId><ArticleId IdType="pmc">PMC8001972</ArticleId><ArticleId IdType="pubmed">33799358</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricciardi D., Todisco V., Tedeschi G., Trojsi F., Cirillo G. Altered sensory-motor plasticity in amyotrophic lateral sclerosis and complex regional pain type I syndrome: A shared mechanism? Neurol. Sci. 2020;41:1919&#x2013;1921. doi: 10.1007/s10072-020-04317-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04317-5</ArticleId><ArticleId IdType="pubmed">32140909</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J., Ma L. Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. J. Magn. Reson. Imaging. 2010;31:305&#x2013;308. doi: 10.1002/jmri.22053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.22053</ArticleId><ArticleId IdType="pubmed">20099342</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Pagani M., Agosta F., Calvo A., Cistaro A., Filippi M. Neuroimaging in amyotrophic lateral sclerosis: Insights into structural and functional changes. Lancet Neurol. 2014;13:1228&#x2013;1240. doi: 10.1016/S1474-4422(14)70167-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70167-X</ArticleId><ArticleId IdType="pubmed">25453462</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Cagnin A., Turkheimer F.E., Miller C.C.J., Shaw C.E., Brooks D.J., Leigh P.N., Banati R.B. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: An [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 2004;15:601&#x2013;609. doi: 10.1016/j.nbd.2003.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2003.12.012</ArticleId><ArticleId IdType="pubmed">15056468</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P., Tauber C., Vercoullie J., Arlicot N., Prunier C., Praline J., Nicolas G., Venel Y., Hommet C., Baulieu J.L., et al. Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e52941. doi: 10.1371/journal.pone.0052941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052941</ArticleId><ArticleId IdType="pmc">PMC3534121</ArticleId><ArticleId IdType="pubmed">23300829</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Canu E., Inuggi A., Chi&#xf2; A., Riva N., Silani V., Calvo A., Messina S., Falini A., Comi G., et al. Resting state functional connectivity alterations in primary lateral sclerosis. Neurobiol. Aging. 2014;35:916&#x2013;925. doi: 10.1016/j.neurobiolaging.2013.09.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.09.041</ArticleId><ArticleId IdType="pubmed">24211007</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F., Valsasina P., Absinta M., Riva N., Sala S., Prelle A., Copetti M., Comola M., Comi G., Filippi M. Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb. Cortex. 2011;21:2291&#x2013;2298. doi: 10.1093/cercor/bhr002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhr002</ArticleId><ArticleId IdType="pubmed">21368084</ArticleId></ArticleIdList></Reference><Reference><Citation>Sala A., Iaccarino L., Fania P., Vanoli E.G., Fallanca F., Pagnini C., Cerami C., Calvo A., Canosa A., Pagani M., et al. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. Eur. J. Nucl. Med. Mol. Imaging. 2019;46:1117&#x2013;1131. doi: 10.1007/s00259-018-4246-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-018-4246-2</ArticleId><ArticleId IdType="pubmed">30617963</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P., Geevasinga N., Yiannikas C., Howells J., Kiernan M.C., Vucic S. Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: A prospective study. Lancet Neurol. 2015;14:478&#x2013;484. doi: 10.1016/S1474-4422(15)00014-9. Correction in Lancet Neurol. 2015, 14, 566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(15)00014-9</ArticleId><ArticleId IdType="pubmed">25843898</ArticleId></ArticleIdList></Reference><Reference><Citation>Shibuya K., Park S.B., Geevasinga N., Menon P., Howells J., Simon N.G., Huynh W., Noto Y.-I., G&#xf6;tz J., Kril J.J., et al. Motor cortical function determines prognosis in sporadic ALS. Neurology. 2016;87:513&#x2013;520. doi: 10.1212/WNL.0000000000002912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002912</ArticleId><ArticleId IdType="pubmed">27402895</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Bokuda K., Kimura H., Kamiyama T., Nakayama Y., Kawata A., Isozaki E., Ugawa Y. Sensory cortex hyperexcitability predicts short survival in amyotrophic lateral sclerosis. Neurology. 2018;90:e1578&#x2013;e1587. doi: 10.1212/WNL.0000000000005424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005424</ArticleId><ArticleId IdType="pubmed">29602913</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R., Golaszewski S., Thomschewski A., Sebastianelli L., Versace V., Brigo F., Orioli A., Saltuari L., H&#xf6;ller Y., Trinka E. Disinhibition of sensory cortex in patients with amyotrophic lateral sclerosis. Neurosci. Lett. 2020;722:134860. doi: 10.1016/j.neulet.2020.134860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2020.134860</ArticleId><ArticleId IdType="pubmed">32097703</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Nakayama Y., Funai A., Morishima R., Hayashi K., Bokuda K., Nakata Y., Isozaki E. Progressive deterioration of sensory cortex excitability in advanced amyotrophic lateral sclerosis with invasive ventilation. Amyotroph. Lateral Scler. Front. Degener. 2020;21:147&#x2013;149. doi: 10.1080/21678421.2019.1704015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1704015</ArticleId><ArticleId IdType="pubmed">31852262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangari S., Giron A., Marrelec G., Pradat P.F., Marchand-Pauvert V. Abnormal cortical brain integration of somatosensory afferents in ALS. Clin. Neurophysiol. 2018;129:874&#x2013;884. doi: 10.1016/j.clinph.2017.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2017.12.008</ArticleId><ArticleId IdType="pubmed">29317192</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki Y., Mizutani T., Shimizu T., Kawata A. Proportional neuronal loss between the primary motor and sensory cortex in amyotrophic lateral sclerosis. Neurosci. Lett. 2011;503:73&#x2013;75. doi: 10.1016/j.neulet.2011.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.08.014</ArticleId><ArticleId IdType="pubmed">21871950</ArticleId></ArticleIdList></Reference><Reference><Citation>Oyanagi K., Mochizuki Y., Nakayama Y., Hayashi K., Shimizu T., Nagao M., Hashimoto T., Yamazaki M., Matsubara S., Komori T. Marked preservation of the visual and olfactory pathways in ALS patients in a totally locked-in state. Clin. Neuropathol. 2015;34:267&#x2013;274. doi: 10.5414/NP300859.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300859</ArticleId><ArticleId IdType="pubmed">26042590</ArticleId></ArticleIdList></Reference><Reference><Citation>Braak H., Brettschneider J., Ludolph A.C., Lee V.M., Trojanowski J.Q., Del Tredici K. Amyotrophic lateral sclerosis&#x2014;A model of corticofugal axonal spread. Nat. Rev. Neurol. 2013;9:708&#x2013;714. doi: 10.1038/nrneurol.2013.221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.221</ArticleId><ArticleId IdType="pmc">PMC3943211</ArticleId><ArticleId IdType="pubmed">24217521</ArticleId></ArticleIdList></Reference><Reference><Citation>Iglesias C., Sangari S., El Mendili M.M., Benali H., Marchand-Pauvert V., Pradat P.F. Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosis. BMJ Open. 2015;5:e007659. doi: 10.1136/bmjopen-2015-007659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2015-007659</ArticleId><ArticleId IdType="pmc">PMC4342589</ArticleId><ArticleId IdType="pubmed">25712823</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgesco M., Salerno A., Carlander B., Leger J.J., Camu W., Billiard M., Cadilhac J. Les potentiels &#xe9;voqu&#xe9;s somesth&#xe9;siques dans la scl&#xe9;rose lat&#xe9;rale amyotrophique et la scl&#xe9;rose lat&#xe9;rale primaire [Somatosensory evoked potentials in amyotrophic lateral sclerosis and primary lateral sclerosis] Rev. Neurol. 1994;150:292&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">7863181</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinovici A. Abnormal somatosensory evoked potentials in amyotrophic lateral sclerosis. Rom. J. Neurol. Psychiatry. 1993;31:273&#x2013;278.</Citation><ArticleIdList><ArticleId IdType="pubmed">8011489</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke R.A., Erwin A., Erwin C.W. Abnormal sensory evoked potentials in amyotrophic lateral sclerosis. Neurology. 1986;36:796&#x2013;801. doi: 10.1212/WNL.36.6.796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.36.6.796</ArticleId><ArticleId IdType="pubmed">3703285</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasheiff R.M., Drake M.E., Brendle A., Erwin C.W. Abnormal somatosensory evoked potentials in amyotrophic lateral sclerosis. Electroencephalogr. Clin. Neurophysiol. 1985;60:306&#x2013;311. doi: 10.1016/0013-4694(85)90004-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0013-4694(85)90004-5</ArticleId><ArticleId IdType="pubmed">2579797</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen-Adad J., El Mendili M.-M., Morizot-Koutlidis R., Leh&#xe9;ricy S., Meininger V., Blancho S., Rossignol S., Benali H., Pradat P.-F. Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph. Lateral Scler. Front. Degener. 2013;14:30&#x2013;38. doi: 10.3109/17482968.2012.701308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.701308</ArticleId><ArticleId IdType="pubmed">22881412</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder D.W., Bushek W., Spring E., Karnes J., Dyck P.J. Motor neuron disease (ALS): Evaluation of detection thresholds of cutaneous sensation. Neurology. 1983;33:1625&#x2013;1627. doi: 10.1212/WNL.33.12.1625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.33.12.1625</ArticleId><ArticleId IdType="pubmed">6685835</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyck P.J., Stevens J.C., Mulder D.W., Espinosa R.E. Frequency of nerve fiber degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. Morphometry of deep and superficial peroneal nerves. Neurology. 1975;25:781&#x2013;785. doi: 10.1212/WNL.25.8.781.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.25.8.781</ArticleId><ArticleId IdType="pubmed">1171412</ArticleId></ArticleIdList></Reference><Reference><Citation>Hammad M., Silva A., Glass J., Sladky J.T., Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology. 2007;69:2236&#x2013;2242. doi: 10.1212/01.wnl.0000286948.99150.16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000286948.99150.16</ArticleId><ArticleId IdType="pubmed">18071143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ince P., Evans J., Knopp M., Forster G., Hamdalla H., Wharton S., Shaw P. Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS. Neurology. 2003;60:1252&#x2013;1258. doi: 10.1212/01.WNL.0000058901.75728.4E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000058901.75728.4E</ArticleId><ArticleId IdType="pubmed">12707426</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A., Kurland L.T., Sayre G.P. Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch. Neurol. 1967;16:232&#x2013;243. doi: 10.1001/archneur.1967.00470210008002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1967.00470210008002</ArticleId><ArticleId IdType="pubmed">6018874</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawyer T., Jr., Netsky M.g. Amyotrophic lateral sclerosis. AMA Arch. Neurol. Psychiatry. 1953;69:171&#x2013;192. doi: 10.1001/archneurpsyc.1953.02320260029002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurpsyc.1953.02320260029002</ArticleId><ArticleId IdType="pubmed">13007227</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Tsutsumi Y., Yamane K., Sakuma H., Maruyama S. Sporadic amyotrophic lateral sclerosis with extensive neurological involvement. Acta Neuropathol. 1992;84:211&#x2013;215. doi: 10.1007/BF00311398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00311398</ArticleId><ArticleId IdType="pubmed">1523976</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura Y., Dyck P.J., Shimono M., Okazaki H., Tateishi J., Doi H. Morphometric comparison of the vulnerability of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1981;40:667&#x2013;675. doi: 10.1097/00005072-198111000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198111000-00008</ArticleId><ArticleId IdType="pubmed">7299423</ArticleId></ArticleIdList></Reference><Reference><Citation>Camdessanch&#xe9; J.-P., Belzil V.V., Jousserand G., Rouleau G.A., Cr&#xe9;ac&#x2019;h C., Convers P., Antoine J.-C. Sensory and motor neuronopathy in a patient with the A382P TDP-43 mutation. Orphanet J. Rare Dis. 2011;6:4. doi: 10.1186/1750-1172-6-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-6-4</ArticleId><ArticleId IdType="pmc">PMC3042904</ArticleId><ArticleId IdType="pubmed">21294910</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeberl F., Abicht A., Kuepper C., Voelk S., Sonnenfeld S., Tonon M., Schaub A., Scholz V., Kleinle S., Erdmann H., et al. Sensory neuropathy due to RFC1 in a patient with ALS: More than a coincidence? J. Neurol. 2022;269:2774&#x2013;2777. doi: 10.1007/s00415-021-10835-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10835-9</ArticleId><ArticleId IdType="pmc">PMC9021066</ArticleId><ArticleId IdType="pubmed">34821988</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Davis A.A., Tennant P., Wang M., Coleman M., Asress S., Adalbert R., Alexander G.M., Glass J.D. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol. Dis. 2005;19:293&#x2013;300. doi: 10.1016/j.nbd.2005.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.01.008</ArticleId><ArticleId IdType="pubmed">15837585</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y.-S., Wu D.-X., Wu H.-R., Wu S.-Y., Yang C., Li B., Bu H., Zhang Y.-S., Li C.-Y. Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Exp. Mol. Med. 2009;41:140&#x2013;150. doi: 10.3858/emm.2009.41.3.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.3858/emm.2009.41.3.017</ArticleId><ArticleId IdType="pmc">PMC2679239</ArticleId><ArticleId IdType="pubmed">19293633</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;bado J., Casanovas A., Tarabal O., Hereu M., Piedrafita L., Calder&#xf3; J., Esquerda J.E. Accumulation of misfolded SOD1 in dorsal root ganglion degenerating proprioceptive sensory neurons of transgenic mice with amyotrophic lateral sclerosis. Biomed. Res. Int. 2014;2014:852163. doi: 10.1155/2014/852163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/852163</ArticleId><ArticleId IdType="pmc">PMC4022303</ArticleId><ArticleId IdType="pubmed">24877142</ArticleId></ArticleIdList></Reference><Reference><Citation>Sassone J., Taiana M., Lombardi R., Porretta-Serapiglia C., Freschi M., Bonanno S., Marcuzzo S., Caravello F., Bendotti C., Lauria G. ALS mouse model SOD1G93A displays early pathology of sensory small fibers associated to accumulation of a neurotoxic splice variant of peripherin. Hum. Mol. Genet. 2016;25:1588&#x2013;1599. doi: 10.1093/hmg/ddw035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw035</ArticleId><ArticleId IdType="pubmed">26908600</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan S.K., Sutherland N.M., Zhang S., Hatzipetros T., Vieira F., Valdez G. The ALS-inducing factors, TDP43A315T and SOD1G93A, directly affect and sensitize sensory neurons to stress. Sci. Rep. 2018;8:16582. doi: 10.1038/s41598-018-34510-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34510-8</ArticleId><ArticleId IdType="pmc">PMC6224462</ArticleId><ArticleId IdType="pubmed">30410094</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh J.N., Mech A.M., Aktar T., Zhang Y., Schiavo G. Altered Sensory Neuron Development in CMT2D Mice Is Site-Specific and Linked to Increased GlyRS Levels. Front. Cell Neurosci. 2020;14:232. doi: 10.3389/fncel.2020.00232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00232</ArticleId><ArticleId IdType="pmc">PMC7431706</ArticleId><ArticleId IdType="pubmed">32848623</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio M.A., Herrando-Grabulosa M., Gaja-Capdevila N., Vilches J.J., Navarro X. Characterization of somatosensory neuron involvement in the SOD1G93A mouse model. Sci. Rep. 2022;12:7600. doi: 10.1038/s41598-022-11767-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-11767-8</ArticleId><ArticleId IdType="pmc">PMC9085861</ArticleId><ArticleId IdType="pubmed">35534694</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone R., H&#xf6;ller Y., Taylor A.C., Lochner P., Tezzon F., Golaszewski S., Brigo F., Trinka E. Canine degenerative myelopathy: A model of human amyotrophic lateral sclerosis. Zoology. 2016;119:64&#x2013;73. doi: 10.1016/j.zool.2015.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.zool.2015.09.003</ArticleId><ArticleId IdType="pubmed">26432396</ArticleId></ArticleIdList></Reference><Reference><Citation>Awano T., Johnson G.S., Wade C.M., Katz M.L., Johnson G.C., Taylor J.F., Perloski M., Biagi T., Baranowska I., Long S., et al. Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2009;106:2794&#x2013;2799. doi: 10.1073/pnas.0812297106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0812297106</ArticleId><ArticleId IdType="pmc">PMC2634802</ArticleId><ArticleId IdType="pubmed">19188595</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugdahl K., Fuglsang-Frederiksen A., De Carvalho M., Johnsen B., Fawcett P.R.W., Labarre-Vila A., Liguori R., Nix W.A., Schofield I.S. Generalised sensory system abnormalities in amyotrophic lateral sclerosis: A European multicentre study. J. Neurol. Neurosurg. Psychiatry. 2007;78:746&#x2013;749. doi: 10.1136/jnnp.2006.098533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.098533</ArticleId><ArticleId IdType="pmc">PMC2117695</ArticleId><ArticleId IdType="pubmed">17575020</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory R., Mills K., Donaghy M. Progressive sensory nerve dysfunction in amyotrophic lateral sclerosis: A prospective clinical and neurophysiological study. J. Neurol. 1993;240:309&#x2013;314. doi: 10.1007/BF00838169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00838169</ArticleId><ArticleId IdType="pubmed">8326338</ArticleId></ArticleIdList></Reference><Reference><Citation>Mondelli M., Rossi A., Passero S., Guazzi G.C. Involvement of peripheral sensory fibers in amyotrophic lateral sclerosis: Electrophysiological study of 64 cases. Muscle Nerve. 1993;16:166&#x2013;172. doi: 10.1002/mus.880160208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880160208</ArticleId><ArticleId IdType="pubmed">8429840</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner J.M., Tyler H.R., Krarup C. Abnormalities in the sensory action potential in patients with amyotrophic lateral sclerosis. Muscle Nerve. 1991;14:1242&#x2013;1246. doi: 10.1002/mus.880141218.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880141218</ArticleId><ArticleId IdType="pubmed">1766456</ArticleId></ArticleIdList></Reference><Reference><Citation>Theys P.A., Peeters E., Robberecht W. Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques. J. Neurol. 1999;246:438&#x2013;442. doi: 10.1007/s004150050379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150050379</ArticleId><ArticleId IdType="pubmed">10431767</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegat A., Bouhour F., Mouzat K., Vial C., Pegat B., Leblanc P., Broussolle E., Millecamps S., Lumbroso S., Bernard E. Electrophysiological characterization of c9orf72-associated amyotrophic lateral sclerosis: A retrospective study. Eur. Neurol. 2019;82:106&#x2013;112. doi: 10.1159/000505777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000505777</ArticleId><ArticleId IdType="pubmed">32018264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kothari M.J., Rutkove S.B., Logigian E.L., Shefner J.M. Coexistent entrapment neuropathies in patients with amyotrophic lateral sclerosis. Arch. Phys. Med. Rehabil. 1996;77:1186&#x2013;1188. doi: 10.1016/S0003-9993(96)90146-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0003-9993(96)90146-X</ArticleId><ArticleId IdType="pubmed">8931534</ArticleId></ArticleIdList></Reference><Reference><Citation>Pugdahl K., Fuglsang-Frederiksen A., Johnsen B., de Carvalho M., Fawcett P.R., Labarre-Vila A., Liguori R., Nix W.A., Schofield I.S. A prospective multicentre study on sural nerve action potentials in ALS. Clin. Neurophysiol. 2008;119:1106&#x2013;1110. doi: 10.1016/j.clinph.2008.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2008.01.010</ArticleId><ArticleId IdType="pubmed">18313354</ArticleId></ArticleIdList></Reference><Reference><Citation>Isak B., Tankisi H., Johnsen B., Pugdahl K., M&#xf8;ller A.T., Finnerup N.B., Christensen P.B., Fuglsang-Frederiksen A. Involvement of distal sensory nerves in amyotrophic lateral sclerosis. Muscle Nerve. 2016;54:1086&#x2013;1092. doi: 10.1002/mus.25157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25157</ArticleId><ArticleId IdType="pubmed">27104485</ArticleId></ArticleIdList></Reference><Reference><Citation>Sista S.R.S., Shelly S., Oskarsson B., Rubin D.I., Martinez-Thompson J.M., Parra-Cantu C., Staff N.P., Laughlin R.S. Clinical and electrophysiological findings in C9ORF72 ALS. Muscle Nerve. 2022;66:270&#x2013;275. doi: 10.1002/mus.27665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27665</ArticleId><ArticleId IdType="pubmed">35727129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., Santos-Nogueira E., Osta R., Navarro X. Electrophysiological analysis of a murine model of motoneuron disease. Clin. Neurophysiol. 2011;122:1660&#x2013;1670. doi: 10.1016/j.clinph.2011.01.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2011.01.045</ArticleId><ArticleId IdType="pubmed">21354365</ArticleId></ArticleIdList></Reference><Reference><Citation>Bo&#xeb;rio D., Kalmar B., Greensmith L., Bostock H. Excitability properties of mouse motor axons in the mutant SOD1(G93A) model of amyotrophic lateral sclerosis. Muscle Nerve. 2010;41:774&#x2013;784. doi: 10.1002/mus.21579.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21579</ArticleId><ArticleId IdType="pubmed">20095022</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawata A., Kato S., Hayashi H., Hirai S. Prominent sensory and autonomic disturbances in familial amyotrophic lateral sclerosis with a Gly93Ser mutation in the SOD1 gene. J. Neurol. Sci. 1997;153:82&#x2013;85. doi: 10.1016/S0022-510X(97)00176-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(97)00176-7</ArticleId><ArticleId IdType="pubmed">9455983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bella E.D., Rigamonti A., Mantero V., Morbin M., Saccucci S., Gellera C., Mora G., Lauria G. Heterozygous D90A-SOD1 mutation in a patient with facial onset sensory motor neuronopathy (FOSMN) syndrome: A bridge to amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2014;85:1009&#x2013;1011. doi: 10.1136/jnnp-2013-307416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-307416</ArticleId><ArticleId IdType="pubmed">24591457</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben Hamida M., Letaief F., Hentati F., Ben Hamida C. Morphometric study of the sensory nerve in classical (or Charcot disease) and juvenile amyotrophic lateral sclerosis. J. Neurol. Sci. 1987;78:313&#x2013;329. doi: 10.1016/0022-510X(87)90045-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(87)90045-1</ArticleId><ArticleId IdType="pubmed">3585405</ArticleId></ArticleIdList></Reference><Reference><Citation>Luigetti M., Conte A., Del Grande A., Bisogni G., Romano A., Sabatelli M. Sural nerve pathology in ALS patients: A single-centre experience. Neurol. Sci. 2012;33:1095&#x2013;1099. doi: 10.1007/s10072-011-0909-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-011-0909-5</ArticleId><ArticleId IdType="pubmed">22203334</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaacs J.D., Dean A.F., Shaw C.E., Al-Chalabi A., Mills K.R., Leigh P.N. Amyotrophic lateral sclerosis with sensory neuropathy: Part of a multisystem disorder? J. Neurol. Neurosurg. Psychiatry. 2007;78:750&#x2013;753. doi: 10.1136/jnnp.2006.098798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.098798</ArticleId><ArticleId IdType="pmc">PMC2117693</ArticleId><ArticleId IdType="pubmed">17575021</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley W.G., Good P., Rasool C.G., Adelman L.S. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann. Neurol. 1983;14:267&#x2013;277. doi: 10.1002/ana.410140304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410140304</ArticleId><ArticleId IdType="pubmed">6195954</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Trapani G., David P., La Cara A., Servidei S., Tonali P. Morphological studies of sural nerve biopsies in the pseudopolyneuropathic form of amyotrophic lateral sclerosis. Clin. Neuropathol. 1986;5:134&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">3720069</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Trapani G., David P., La Cara A., Tonali P., Laurienzo P. Light and ultrastructural studies in sural biopsies of the pseudopolyneuropathic form of ALS. Adv. Exp. Med. Biol. 1987;209:111&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pubmed">3577898</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayan A.D., Graveson G.S., Illis L.S., Robinson P.K. Schwann cell damage in motoneuron disease. Neurology. 1969;19:242&#x2013;246. doi: 10.1212/WNL.19.3.242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.19.3.242</ArticleId><ArticleId IdType="pubmed">5812979</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold N., Harriman D.G. The incidence of abnormality in control human peripheral nerves studied by single axon dissection. J. Neurol. Neurosurg. Psychiatry. 1970;33:55&#x2013;61. doi: 10.1136/jnnp.33.1.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.33.1.55</ArticleId><ArticleId IdType="pmc">PMC493407</ArticleId><ArticleId IdType="pubmed">5418180</ArticleId></ArticleIdList></Reference><Reference><Citation>Heads T., Pollock M., Robertson A., Sutherland W.H., Allpress S. Sensory nerve pathology in amyotrophic lateral sclerosis. Acta Neuropathol. 1991;82:316&#x2013;320. doi: 10.1007/BF00308818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00308818</ArticleId><ArticleId IdType="pubmed">1662002</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M., Melamed E., Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J. Mol. Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler E.A., Sengillo J.D., Sagare A.P., Zhao Z., Ma Q., Zuniga E., Wang Y., Zhong Z., Sullivan J.S., Griffin J.H., et al. Blood-spinal cord barrier disruption contributes to early motor-neuron degeneration in ALS-model mice. Proc. Natl. Acad. Sci. USA. 2014;111:E1035&#x2013;E1042. doi: 10.1073/pnas.1401595111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401595111</ArticleId><ArticleId IdType="pmc">PMC3964055</ArticleId><ArticleId IdType="pubmed">24591593</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbuzova-Davis S., Hernandez-Ontiveros D.G., Rodrigues M.C., Haller E., Frisina-Deyo A., Mirtyl S., Sallot S., Saporta S., Borlongan C.V., Sanberg P.R. Impaired blood-brain/spinal cord barrier in ALS patients. Brain Res. 2012;1469:114&#x2013;128. doi: 10.1016/j.brainres.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.05.056</ArticleId><ArticleId IdType="pubmed">22750125</ArticleId></ArticleIdList></Reference><Reference><Citation>Alanne M.H., Pummi K., Heape A.M., Gr&#xe8;nman R., Peltonen J., Peltonen S. Tight junction proteins in human Schwann cell autotypic junctions. J. Histochem. Cytochem. 2009;57:523&#x2013;529. doi: 10.1369/jhc.2009.951681.</Citation><ArticleIdList><ArticleId IdType="doi">10.1369/jhc.2009.951681</ArticleId><ArticleId IdType="pmc">PMC2690405</ArticleId><ArticleId IdType="pubmed">19153196</ArticleId></ArticleIdList></Reference><Reference><Citation>Riva N., Gentile F., Cerri F., Gallia F., Podini P., Dina G., Falzone Y.M., Fazio R., Lunetta C., Calvo A., et al. Phosphorylated TDP-43 aggregates in peripheral motor nerves of patients with amyotrophic lateral sclerosis. Brain. 2022;145:276&#x2013;284. doi: 10.1093/brain/awab285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab285</ArticleId><ArticleId IdType="pmc">PMC8967102</ArticleId><ArticleId IdType="pubmed">35076694</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmatis L., Atallah G., Scott S.H., Taylor S. The feasibility of using robotic technology to quantify sensory, motor, and cognitive impairments associated with ALS. Amyotroph. Lateral Scler. Front. Degener. 2019;20:43&#x2013;52. doi: 10.1080/21678421.2018.1550515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1550515</ArticleId><ArticleId IdType="pubmed">30688092</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieg I., Dalin D., Heimbach B., Wiesmeier I.K., Maurer C. Abnormal trunk control determines postural abnormalities in Amyotrophic Lateral Sclerosis. NeuroRehabilitation. 2019;44:599&#x2013;608. doi: 10.3233/NRE-192698.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-192698</ArticleId><ArticleId IdType="pmc">PMC6700719</ArticleId><ArticleId IdType="pubmed">31256087</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardone A., Galante M., Lucas B., Schieppati M. Stance control is not affected by paresis and reflex hyperexcitability: The case of spastic patients. J. Neurol. Neurosurg. Psychiatry. 2001;70:635&#x2013;643. doi: 10.1136/jnnp.70.5.635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.70.5.635</ArticleId><ArticleId IdType="pmc">PMC1737341</ArticleId><ArticleId IdType="pubmed">11309458</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruoppolo G., Onesti E., Gori M.C., Schettino I., Frasca V., Biasiotta A., Giordano C., Ceccanti M., Cambieri C., Greco A., et al. Laryngeal sensitivity in patients with amyotrophic lateral sclerosis. Front. Neurol. 2016;7:212. doi: 10.3389/fneur.2016.00212.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2016.00212</ArticleId><ArticleId IdType="pmc">PMC5124602</ArticleId><ArticleId IdType="pubmed">27965622</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan S.K., Kemp Z., Hatzipetros T., Vieira F., Valdez G. Degeneration of proprioceptive sensory nerve endings in mice harboring amyotrophic lateral sclerosis-causing mutations. J. Comp. Neurol. 2015;523:2477&#x2013;2494. doi: 10.1002/cne.23848.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23848</ArticleId><ArticleId IdType="pmc">PMC5759336</ArticleId><ArticleId IdType="pubmed">26136049</ArticleId></ArticleIdList></Reference><Reference><Citation>Seki S., Yamamoto T., Quinn K., Spigelman I., Pantazis A., Olcese R., Wiedau-Pazos M., Chandler S.H., Venugopal S. Circuit-specific early impairment of proprioceptive sensory neurons in the SOD1G93A mouse model for ALS. J. Neurosci. 2019;39:8798&#x2013;8815. doi: 10.1523/JNEUROSCI.1214-19.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1214-19.2019</ArticleId><ArticleId IdType="pmc">PMC6820216</ArticleId><ArticleId IdType="pubmed">31530644</ArticleId></ArticleIdList></Reference><Reference><Citation>Held A., Major P., Sahin A., Reenan R.A., Lipscombe D., Wharton K.A. Circuit dysfunction in SOD1-ALS model first detected in sensory feedback prior to motor neuron degeneration is alleviated by BMP signaling. J. Neurosci. 2019;39:2347&#x2013;2364. doi: 10.1523/JNEUROSCI.1771-18.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1771-18.2019</ArticleId><ArticleId IdType="pmc">PMC6433758</ArticleId><ArticleId IdType="pubmed">30659087</ArticleId></ArticleIdList></Reference><Reference><Citation>Wootz H., FitzSimons-Kantamneni E., Larhammar M., Rotterman T.M., Enjin A., Patra K., Andr&#xe9; E., Van Zundert B., Kullander K., Alvarez F.J. Alterations in the motor neuron-renshaw cell circuit in the Sod1(G93A) mouse model. J. Comp. Neurol. 2013;521:1449&#x2013;1469. doi: 10.1002/cne.23266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23266</ArticleId><ArticleId IdType="pmc">PMC3604165</ArticleId><ArticleId IdType="pubmed">23172249</ArticleId></ArticleIdList></Reference><Reference><Citation>Siembab V.C., Gomez-Perez L., Rotterman T.M., Shneider N.A., Alvarez F.J. Role of primary afferents in the developmental regulation of motor axon synapse numbers on Renshaw cells. J. Comp. Neurol. 2016;524:1892&#x2013;1919. doi: 10.1002/cne.23946.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23946</ArticleId><ArticleId IdType="pmc">PMC4833563</ArticleId><ArticleId IdType="pubmed">26660356</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M., Misawa H., Kato S., Hirai S. Loss of cholinergic synapses on the spinal motor neurons of amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1998;57:329&#x2013;333. doi: 10.1097/00005072-199804000-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199804000-00004</ArticleId><ArticleId IdType="pubmed">9600225</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas C., Herrando-Grabulosa M., Manzano R., Mancuso R., Osta R., Navarro X. Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav. 2013;3:145&#x2013;158. doi: 10.1002/brb3.104. Correction in Brain Behav. 2013, 3, 328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.104</ArticleId><ArticleId IdType="pmc">PMC3607155</ArticleId><ArticleId IdType="pubmed">23531559</ArticleId></ArticleIdList></Reference><Reference><Citation>Murayama S., Ookawa Y., Mori H., Nakano I., Ihara Y., Kuzuhara S., Tomonaga M. Immunocytochemical and ultrastructural study of Lewy body-like hyaline inclusions in familial amyotrophic lateral sclerosis. Acta Neuropathol. 1989;78:143&#x2013;152. doi: 10.1007/BF00688202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00688202</ArticleId><ArticleId IdType="pubmed">2473594</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C., Kozlowski M.A., Hinton D.R., Miller C.A. Degeneration of spinocerebellar neurons in amyotrophic lateral sclerosis. Ann. Neurol. 1990;27:215&#x2013;225. doi: 10.1002/ana.410270302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410270302</ArticleId><ArticleId IdType="pubmed">2327732</ArticleId></ArticleIdList></Reference><Reference><Citation>Kokubo Y., Kuzuhara S., Narita Y., Kikugawa K., Nakano R., Inuzuka T., Tsuji S., Watanabe M., Miyazaki T., Murayama S., et al. Accumulation of neurofilaments and SOD1-immunoreactive products in a patient with familial amyotrophic lateral sclerosis with I113T SOD1 mutation. Arch. Neurol. 1999;56:1506&#x2013;1508. doi: 10.1001/archneur.56.12.1506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.56.12.1506</ArticleId><ArticleId IdType="pubmed">10593307</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujita Y., Ikeda M., Yanagisawa T., Senoo Y., Okamoto K. Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation. Neurology. 2011;77:1427&#x2013;1431. doi: 10.1212/WNL.0b013e318232ab87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318232ab87</ArticleId><ArticleId IdType="pubmed">21956716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H.S., Yamanaka K., Malkmus S., Kakinohana O., Yaksh T., Marsala M., Cleveland D.W. Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc. Natl. Acad. Sci. USA. 2008;105:12599&#x2013;12604. doi: 10.1073/pnas.0805422105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0805422105</ArticleId><ArticleId IdType="pmc">PMC2527957</ArticleId><ArticleId IdType="pubmed">18719118</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M., Sharma A., Lyashchenko A.K., Shneider N.A. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc. Natl. Acad. Sci. USA. 2016;113:E8316&#x2013;E8325. doi: 10.1073/pnas.1605210113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Mentis G.Z., Blivis D., Liu W., Drobac E., Crowder M.E., Kong L., Alvarez F.J., Sumner C.J., O&#x2019;Donovan M.J. Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron. 2011;69:453&#x2013;467. doi: 10.1016/j.neuron.2010.12.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.12.032</ArticleId><ArticleId IdType="pmc">PMC3044334</ArticleId><ArticleId IdType="pubmed">21315257</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagnini F., Lunetta C., Banfi P., Rossi G., Fossati F., Marconi A., Castelnuovo G., Corbo M., Molinari E. Pain in amyotrophic lateral sclerosis: A psychological perspective. Neurol. Sci. 2012;33:1193&#x2013;1196. doi: 10.1007/s10072-011-0888-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-011-0888-6</ArticleId><ArticleId IdType="pubmed">22183268</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzimenti A., Aragona M., Onesti E., Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: A cross-sectional study. Funct. Neurol. 2013;28:115&#x2013;119. doi: 10.11138/FNeur/2013.28.2.115.</Citation><ArticleIdList><ArticleId IdType="doi">10.11138/FNeur/2013.28.2.115</ArticleId><ArticleId IdType="pmc">PMC3812727</ArticleId><ArticleId IdType="pubmed">24125561</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch F., Skudlarek A., Berndt J., Kornhuber M.E. Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav. 2015;5:e00296. doi: 10.1002/brb3.296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.296</ArticleId><ArticleId IdType="pmc">PMC4309879</ArticleId><ArticleId IdType="pubmed">25642388</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Canosa A., Gallo S., Moglia C., Ilardi A., Cammarosano S., Papurello D., Calvo A. Pain in amyotrophic lateral sclerosis: A population-based controlled study. Eur. J. Neurol. 2012;19:551&#x2013;555. doi: 10.1111/j.1468-1331.2011.03540.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03540.x</ArticleId><ArticleId IdType="pubmed">21972798</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.S., Zhang J., Zheng J.Y., Zhang S., Kang D.X., Fan D.S. Fully intact contact heat evoked potentials in patients with amyotrophic lateral sclerosis. Muscle Nerve. 2009;39:735&#x2013;738. doi: 10.1002/mus.21232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21232</ArticleId><ArticleId IdType="pubmed">19260053</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone I.L., Tortelli R., Samarelli V., D&#x2019;Errico E., Sardaro M., Difruscolo O., Calabrese R., Francesco V.D.V., Livrea P., de Tommaso M. Laser evoked potentials in amyotrophic lateral sclerosis. J. Neurol. Sci. 2010;288:106&#x2013;111. doi: 10.1016/j.jns.2009.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2009.09.023</ArticleId><ArticleId IdType="pubmed">19836030</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepika J., Manvir B., Sumit S., Vinay G., Trilochan S., Garima S., Padma M.V., Madhuri B. Quantitative thermal sensory testing in patients with amyotrophic lateral sclerosis using reaction time exclusive method of levels (MLE) Electromyogr. Clin. Neurophysiol. 2006;46:145&#x2013;148.</Citation><ArticleIdList><ArticleId IdType="pubmed">16918198</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes L., Galhardoni R., Silva V., Jorge F., Yeng L., Callegaro D., Chadi G., Teixeira M., de Andrade D.C. Beyond weakness: Characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: A controlled study. Eur. J. Pain. 2018;22:72&#x2013;83. doi: 10.1002/ejp.1091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejp.1091</ArticleId><ArticleId IdType="pubmed">28833988</ArticleId></ArticleIdList></Reference><Reference><Citation>Truini A., Biasiotta A., Onesti E., Di Stefano G., Ceccanti M., La Cesa S., Pepe A., Giordano C., Cruccu G., Inghilleri M. Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS. J. Neurol. 2015;262:1014&#x2013;1018. doi: 10.1007/s00415-015-7672-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7672-0</ArticleId><ArticleId IdType="pubmed">25683764</ArticleId></ArticleIdList></Reference><Reference><Citation>Treede R.D., Meyer R.A., Campbell J.N. Myelinated mechanically insensitive afferents from monkey hairy skin: Heat-response properties. J. Neurophysiol. 1998;80:1082&#x2013;1093. doi: 10.1152/jn.1998.80.3.1082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.1998.80.3.1082</ArticleId><ArticleId IdType="pubmed">9744923</ArticleId></ArticleIdList></Reference><Reference><Citation>Weis J., Katona I., Muller-Newen G., Sommer C., Necula G., Hendrich C., Ludolph A.C., Sperfeld A.D. Small-fiber neuropathy in patients with ALS. Neurology. 2011;76:2024&#x2013;2029. doi: 10.1212/WNL.0b013e31821e553a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821e553a</ArticleId><ArticleId IdType="pubmed">21646630</ArticleId></ArticleIdList></Reference><Reference><Citation>Nolano M., Provitera V., Manganelli F., Iodice R., Caporaso G., Stancanelli A., Marinou K., Lanzillo B., Santoro L., Mora G. Non-motor involvement in amyotrophic lateral sclerosis: New insight from nerve and vessel analysis in skin biopsy. Neuropathol. Appl. Neurobiol. 2017;43:119&#x2013;132. doi: 10.1111/nan.12332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12332</ArticleId><ArticleId IdType="pubmed">27288647</ArticleId></ArticleIdList></Reference><Reference><Citation>Isak B., Pugdahl K., Karlsson P., Tankisi H., Finnerup N.B., Furtula J., Johnsen B., Sunde N., Jakobsen J., Fuglsang-Frederiksen A. Quantitative sensory testing and structural assessment of sensory nerve fibres in amyotrophic lateral sclerosis. J. Neurol. Sci. 2017;373:329&#x2013;334. doi: 10.1016/j.jns.2017.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.01.005</ArticleId><ArticleId IdType="pubmed">28131214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalla Bella E., Lombardi R., Porretta-Serapiglia C., Ciano C., Gellera C., Pensato V., Cazzato D., Lauria G. Amyotrophic lateral sclerosis causes small fiber pathology. Eur. J. Neurol. 2016;23:416&#x2013;420. doi: 10.1111/ene.12936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12936</ArticleId><ArticleId IdType="pubmed">26806218</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio M.A., Herrando-Grabulosa M., Velasco R., Blasco I., Povedano M., Navarro X. TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients. Cells. 2022;11:209. doi: 10.3390/cells11020209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11020209</ArticleId><ArticleId IdType="pmc">PMC8773870</ArticleId><ArticleId IdType="pubmed">35053327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Y., Liu W., Li Y., Sun B., Li Y., Yang F., Wang H., Li M., Cui F., Huang X. Cutaneous somatic and autonomic nerve TDP-43 deposition in amyotrophic lateral sclerosis. J. Neurol. 2018;265:1753&#x2013;1763. doi: 10.1007/s00415-018-8897-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8897-5</ArticleId><ArticleId IdType="pubmed">29804146</ArticleId></ArticleIdList></Reference><Reference><Citation>Gen&#xe7; B., Lagrimas A.K.B., Kuru P., Hess R., Tu M.W., Menichella D.M., Miller R.J., Paller A.S., Ozdinler P.H. Visualization of sensory neurons and their projections in an upper motor neuron reporter line. PLoS ONE. 2015;10:e0132815. doi: 10.1371/journal.pone.0132815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132815</ArticleId><ArticleId IdType="pmc">PMC4519325</ArticleId><ArticleId IdType="pubmed">26222784</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubio M.A., Herrando-Grabulosa M., Vilches J.J., Navarro X. Involvement of sensory innervation in the skin of SOD1(G93A) ALS mice. J. Peripher. Nerv. Syst. 2016;21:88&#x2013;95. doi: 10.1111/jns.12164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jns.12164</ArticleId><ArticleId IdType="pubmed">26880731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari G., Grisan E., Scarpa F., Efazio R., Ecomola M., Quattrini A., Ecomi G., Rama P., Eriva N. Corneal confocal microscopy reveals trigeminal small sensory fiber neuropathy in amyotrophic lateral sclerosis. Front. Aging Neurosci. 2014;6:278. doi: 10.3389/fnagi.2014.00278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00278</ArticleId><ArticleId IdType="pmc">PMC4199282</ArticleId><ArticleId IdType="pubmed">25360111</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin M.R., Harris D., Cassel S.G., Grimes E., Heiman-Patterson T. Sensory testing in the assessment of laryngeal sensation in patients with amyotrophic lateral sclerosis. Ann. Otol. Rhinol. Laryngol. 2006;115:528&#x2013;534. doi: 10.1177/000348940611500707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/000348940611500707</ArticleId><ArticleId IdType="pubmed">16900807</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabor-Gray L., Vasilopoulos T., Wheeler-Hegland K., Wymer J., Plowman E.K. Reflexive airway sensorimotor responses in individuals with amyotrophic lateral sclerosis. Dysphagia. 2021;36:574&#x2013;582. doi: 10.1007/s00455-020-10171-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00455-020-10171-6</ArticleId><ArticleId IdType="pubmed">32778945</ArticleId></ArticleIdList></Reference><Reference><Citation>Gwathmey K.G. Sensory neuronopathies. Muscle Nerve. 2016;53:8&#x2013;19. doi: 10.1002/mus.24943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24943</ArticleId><ArticleId IdType="pubmed">26467754</ArticleId></ArticleIdList></Reference><Reference><Citation>Averbuch-Heller L., Helmchen C., Horn A.K., Leigh R.J., B&#xfc;ttner-Ennerver J.A. Slow vertical saccades in motor neuron disease: Correlation of structure and function. Ann. Neurol. 1998;44:641&#x2013;648. doi: 10.1002/ana.410440410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440410</ArticleId><ArticleId IdType="pubmed">9778263</ArticleId></ArticleIdList></Reference><Reference><Citation>Gizzi M., DiRocco A., Sivak M., Cohen B. Ocular motor function in motor neuron disease. Neurology. 1992;42:1037&#x2013;1046. doi: 10.1212/WNL.42.5.1037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.42.5.1037</ArticleId><ArticleId IdType="pubmed">1579227</ArticleId></ArticleIdList></Reference><Reference><Citation>Puligheddu M., Congiu P., Aric&#xf2; D., Rundo F., Borghero G., Marrosu F., Fantini M.L., Ferri R. Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis. Sleep Med. 2016;26:16&#x2013;22. doi: 10.1016/j.sleep.2016.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2016.05.016</ArticleId><ArticleId IdType="pubmed">28007355</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nte T.F., Tr&#xf6;ger M.C., Nusser I., Wieringa B.M., Johannes S., Matzke M., Dengler R. Alteration of early components of the visual evoked potential in amyotrophic lateral sclerosis. J. Neurol. 1998;245:206&#x2013;210. doi: 10.1007/s004150050206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004150050206</ArticleId><ArticleId IdType="pubmed">9591221</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas P., Ram&#xed;rez A.I., Fern&#xe1;ndez-Albarral J.A., L&#xf3;pez-Cuenca I., Salobrar-Garc&#xed;a E., Cadena M., Elvira-Hurtado L., Salazar J.J., De Hoz R., Ram&#xed;rez J.M. Amyotrophic lateral sclerosis: A neurodegenerative motor neuron disease with ocular involvement. Front. Neurosci. 2020;14:566858. doi: 10.3389/fnins.2020.566858.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.566858</ArticleId><ArticleId IdType="pmc">PMC7544921</ArticleId><ArticleId IdType="pubmed">33071739</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Wang H., Fan D., Wang W. Comparison of optical coherence tomography findings and visual field changes in patients with primary open-angle glaucoma and amyotrophic lateral sclerosis. J. Clin. Neurosci. 2018;48:233&#x2013;237. doi: 10.1016/j.jocn.2017.10.080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2017.10.080</ArticleId><ArticleId IdType="pubmed">29169899</ArticleId></ArticleIdList></Reference><Reference><Citation>Volpe N.J., Simonett J., Fawzi A.A., Siddique T. Ophthalmic manifestations of amyotrophic lateral sclerosis (an American Ophthalmological Society Thesis) Trans. Am. Ophthalmol. Soc. 2015;113:T12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4731009</ArticleId><ArticleId IdType="pubmed">26877563</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss H.E., Samelson M., Mohan G., Jiang Q.L. High and low contrast visual acuity are not affected in amyotrophic lateral sclerosis. PLoS ONE. 2016;11:e0168714. doi: 10.1371/journal.pone.0168714.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168714</ArticleId><ArticleId IdType="pmc">PMC5199071</ArticleId><ArticleId IdType="pubmed">28033389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas P., de Hoz R., Ram&#xed;rez A., Ferreras A., Salobrar-Garcia E., Mu&#xf1;oz-Blanco J., Urcelay-Segura J., Salazar J., Ram&#xed;rez J. Changes in retinal OCT and their correlations with neurological disability in early ALS patients, a follow-up study. Brain Sci. 2019;9:337. doi: 10.3390/brainsci9120337.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci9120337</ArticleId><ArticleId IdType="pmc">PMC6955774</ArticleId><ArticleId IdType="pubmed">31771268</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss H.E., McCluskey L., Elman L., Hoskins K., Talman L., Grossman M., Balcer L.J., Galetta S.L., Liu G.T. Cross-sectional evaluation of clinical neuro-ophthalmic abnormalities in an amyotrophic lateral sclerosis population. J. Neurol. Sci. 2012;314:97&#x2013;101. doi: 10.1016/j.jns.2011.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2011.10.016</ArticleId><ArticleId IdType="pmc">PMC3441141</ArticleId><ArticleId IdType="pubmed">22192877</ArticleId></ArticleIdList></Reference><Reference><Citation>Fawzi A.A., Simonett J.M., Purta P., Moss H., Lowry J.L., Deng H.-X., Siddique N., Sufit R., Bigio E.H., Volpe N.J., et al. Clinicopathologic report of ocular involvement in ALS patients with C9orf72 mutation. Amyotroph. Lateral Scler. Front. Degener. 2014;15:569&#x2013;580. doi: 10.3109/21678421.2014.951941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.951941</ArticleId><ArticleId IdType="pmc">PMC4327840</ArticleId><ArticleId IdType="pubmed">25319030</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghezzi A., Mazzalovo E., Locatelli C., Zibetti A., Zaffaroni M., Montanini R. Multimodality evoked potentials in amyotrophic lateral sclerosis. Acta Neurol. Scand. 1989;79:353&#x2013;356. doi: 10.1111/j.1600-0404.1989.tb03799.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1989.tb03799.x</ArticleId><ArticleId IdType="pubmed">2741665</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma V., Guadagnino M., Brescia Morra V., Nolfe G. Multimodality evoked potentials in sporadic amyotrophic lateral sclerosis: A statistical approach. Electromyogr. Clin. Neurophysiol. 1993;33:167&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pubmed">8495658</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson J.K., Harrington H.J., Hallett M. Abnormalities of multimodality evoked potentials in amyotrophic lateral sclerosis. Arch. Neurol. 1986;43:338&#x2013;340. doi: 10.1001/archneur.1986.00520040026013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1986.00520040026013</ArticleId><ArticleId IdType="pubmed">3954617</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; D., Diekmann V., M&#xfc;ller H.P., Kassubek J., Ludolph A.C., Birbaumer N. Neuroimaging of multimodal sensory stimulation in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2010;81:899&#x2013;906. doi: 10.1136/jnnp.2009.192260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.192260</ArticleId><ArticleId IdType="pubmed">20543183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ringer C., Weihe E., Sch&#xfc;tz B. SOD1G93A mutant mice develop a neuroinflammation-independent dendropathy in excitatory neuronal subsets of the olfactory bulb and retina. J. Neuropathol. Exp. Neurol. 2017;76:769&#x2013;778. doi: 10.1093/jnen/nlx057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/nlx057</ArticleId><ArticleId IdType="pubmed">28859334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kushner P.D., Stephenson D.T., Wright S. Reactive astrogliosis is widespread in the subcortical white matter of amyotrophic lateral sclerosis brain. J. Neuropathol. Exp. Neurol. 1991;50:263&#x2013;277. doi: 10.1097/00005072-199105000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199105000-00008</ArticleId><ArticleId IdType="pubmed">2022968</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrecht P., M&#xfc;ller A.-K., S&#xfc;dmeyer M., Ferrea S., Ringelstein M., Cohn E., Aktas O., Dietlein T., Lappas A., Foerster A., et al. Optical coherence tomography in parkinsonian syndromes. PLoS ONE. 2012;7:e34891. doi: 10.1371/journal.pone.0034891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0034891</ArticleId><ArticleId IdType="pmc">PMC3325949</ArticleId><ArticleId IdType="pubmed">22514688</ArticleId></ArticleIdList></Reference><Reference><Citation>Siger M., Dziegielewski K., Jasek L., Bieniek M., Nicpan A., Nawrocki J., Selmaj K. Optical coherence tomography in multiple sclerosis: Thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy. J. Neurol. 2008;255:1555&#x2013;1560. doi: 10.1007/s00415-008-0985-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-008-0985-5</ArticleId><ArticleId IdType="pubmed">18825432</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee N., McBurney-Lin S., Kuo A., Bedlack R., Tseng H. Retinal thinning in amyotrophic lateral sclerosis patients without ophthalmic disease. PLoS ONE. 2017;12:e0185242. doi: 10.1371/journal.pone.0185242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0185242</ArticleId><ArticleId IdType="pmc">PMC5612691</ArticleId><ArticleId IdType="pubmed">28945811</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohani M., Meysamie A., Zamani B., Sowlat M.M., Akhoundi F.H. Reduced retinal nerve fiber layer (RNFL) thickness in ALS patients: A window to disease progression. J. Neurol. 2018;265:1557&#x2013;1562. doi: 10.1007/s00415-018-8863-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8863-2</ArticleId><ArticleId IdType="pubmed">29713825</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;bers A., M&#xfc;ller H.P., Dreyhaupt J., B&#xf6;hm K., Lauda F., Tumani H., Kassubek J., Ludolph A.C., Pinkhardt E.H. Retinal involvement in amyotrophic lateral sclerosis: A study with optical coherence tomography and diffusion tensor imaging. J. Neural Transm. 2016;123:281&#x2013;287. doi: 10.1007/s00702-015-1483-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-015-1483-4</ArticleId><ArticleId IdType="pubmed">26582428</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonett J.M., Huang R., Siddique N., Farsiu S., Siddique T., Volpe N.J., Fawzi A.A. Macular sub-layer thinning and association with pulmonary function tests in Amyotrophic Lateral Sclerosis. Sci. Rep. 2016;6:29187. doi: 10.1038/srep29187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep29187</ArticleId><ArticleId IdType="pmc">PMC4935870</ArticleId><ArticleId IdType="pubmed">27383525</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerver&#xf3; A., Casado A., Riancho J. Retinal changes in amyotrophic lateral sclerosis: Looking at the disease through a new window. J. Neurol. 2021;268:2083&#x2013;2089. doi: 10.1007/s00415-019-09654-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09654-w</ArticleId><ArticleId IdType="pubmed">31792674</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth N.M., Saidha S., Zimmermann H., Brandt A.U., Oberwahrenbrock T., Maragakis N.J., Tumani H., Ludolph A.C., Meyer T., Calabresi P., et al. Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis. Eur. J. Neurol. 2013;20:1170&#x2013;1176. doi: 10.1111/ene.12146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12146</ArticleId><ArticleId IdType="pubmed">23582075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward M.E., Taubes A., Chen R., Miller B.L., Sephton C.F., Gelfand J.M., Minami S., Boscardin J., Martens L.H., Seeley W.W., et al. Early retinal neurodegeneration and impaired Ran-mediated nuclear import of TDP-43 in progranulin-deficient FTLD. J. Exp. Med. 2014;211:1937&#x2013;1945. doi: 10.1084/jem.20140214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20140214</ArticleId><ArticleId IdType="pmc">PMC4172214</ArticleId><ArticleId IdType="pubmed">25155018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma K., Amin M.A.M., Gupta N., Zinman L., Zhou X., Irving H., Y&#xfc;cel Y. Retinal spheroids and axon pathology identified in amyotrophic lateral sclerosis. Investig. Ophthalmol. Vis. Sci. 2020;61:30. doi: 10.1167/iovs.61.13.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.61.13.30</ArticleId><ArticleId IdType="pmc">PMC7691787</ArticleId><ArticleId IdType="pubmed">33226405</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho K.I., Yoon D., Yu M., Peachey N.S., Ferreira P.A. Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 loss and nucleocytoplasmic transport impairment in retinal ganglion neurons. Cell Mol. Life Sci. 2019;76:3407&#x2013;3432. doi: 10.1007/s00018-019-03078-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03078-5</ArticleId><ArticleId IdType="pmc">PMC6698218</ArticleId><ArticleId IdType="pubmed">30944974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira P.A. The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration. Cell Mol. Life Sci. 2019;76:2247&#x2013;2273. doi: 10.1007/s00018-019-03029-0. Correction in Cell Mol. Life Sci. 2019, 76, 2275.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03029-0</ArticleId><ArticleId IdType="pmc">PMC6531325</ArticleId><ArticleId IdType="pubmed">30742233</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.Z., Hashemi S.H., Anderson S.K., Huang Y., Moreira M.C., Lynch D.R., Glass I.A., Chance P.F., Bennett C.L. Senataxin, the yeast Sen1p orthologue: Characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. Neurobiol. Dis. 2006;23:97&#x2013;108. doi: 10.1016/j.nbd.2006.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.02.007</ArticleId><ArticleId IdType="pubmed">16644229</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelhak A., H&#xfc;bers A., B&#xf6;hm K., Ludolph A.C., Kassubek J., Pinkhardt E.H. In vivo assessment of retinal vessel pathology in amyotrophic lateral sclerosis. J. Neurol. 2018;265:949&#x2013;953. doi: 10.1007/s00415-018-8787-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8787-x</ArticleId><ArticleId IdType="pubmed">29464376</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce J.M., Shone G.R. Effects of ageing on smell and taste. Postgrad. Med. J. 2006;82:239&#x2013;241. doi: 10.1136/pgmj.2005.039453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2005.039453</ArticleId><ArticleId IdType="pmc">PMC2579627</ArticleId><ArticleId IdType="pubmed">16597809</ArticleId></ArticleIdList></Reference><Reference><Citation>Landis B.N., Konnerth C.G., Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope. 2004;114:1764&#x2013;1769. doi: 10.1097/00005537-200410000-00017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005537-200410000-00017</ArticleId><ArticleId IdType="pubmed">15454769</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouby C., Thomas-Danguin T., Vigouroux M., Ciuperca G., Jiang T., Alexanian J., Barges M., Gallice I., Degraix J.-L., Sicard G. The lyon clinical olfactory test: Validation and measurement of hyposmia and anosmia in healthy and diseased populations. Int. J. Otolaryngol. 2011;2011:203805. doi: 10.1155/2011/203805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/203805</ArticleId><ArticleId IdType="pmc">PMC3199207</ArticleId><ArticleId IdType="pubmed">22046188</ArticleId></ArticleIdList></Reference><Reference><Citation>Growdon M.E., Schultz A.P., Dagley A.S., Amariglio R.E., Hedden T., Rentz D.M., Johnson K.A., Sperling R.A., Albers M.W., Marshall G.A. Odor identification and Alzheimer disease biomarkers in clinically normal elderly. Neurology. 2015;84:2153&#x2013;2160. doi: 10.1212/WNL.0000000000001614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001614</ArticleId><ArticleId IdType="pmc">PMC4451046</ArticleId><ArticleId IdType="pubmed">25934852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings D., Siderowf A., Stern M., Seibyl J., Eberly S., Oakes D., Marek K. Imaging prodromal Parkinson disease: The Parkinson Associated Risk Syndrome Study. Neurology. 2014;83:1739&#x2013;1746. doi: 10.1212/WNL.0000000000000960.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000960</ArticleId><ArticleId IdType="pmc">PMC4239830</ArticleId><ArticleId IdType="pubmed">25298306</ArticleId></ArticleIdList></Reference><Reference><Citation>Elian M. Olfactory impairment in motor neuron disease: A pilot study. J. Neurol. Neurosurg. Psychiatry. 1991;54:927&#x2013;928. doi: 10.1136/jnnp.54.10.927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.54.10.927</ArticleId><ArticleId IdType="pmc">PMC1014581</ArticleId><ArticleId IdType="pubmed">1744650</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlskog J.E., Waring S.C., Petersen R.C., Esteban-Santillan C., Craig U.-K., O&#x2019;Brien P.C., Plevak M.F., Kurland L.T. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology. 1998;51:1672&#x2013;1677. doi: 10.1212/WNL.51.6.1672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.51.6.1672</ArticleId><ArticleId IdType="pubmed">9855521</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawkes C.H., Shephard B.C., Geddes J.F., Body G.D., Martin J.E. Olfactory disorder in motor neuron disease. Exp. Neurol. 1998;150:248&#x2013;253. doi: 10.1006/exnr.1997.6773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1997.6773</ArticleId><ArticleId IdType="pubmed">9527894</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T., Iijima M., Uchihara T., Ohashi T., Seilhean D., Duyckaerts C., Uchiyama S. TDP-43 pathology progression along the olfactory pathway as a possible substrate for olfactory impairment in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2015;74:547&#x2013;556. doi: 10.1097/NEN.0000000000000198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0000000000000198</ArticleId><ArticleId IdType="pubmed">25933387</ArticleId></ArticleIdList></Reference><Reference><Citation>Viguera C., Wang J., Mosmiller E., Cerezo A., Maragakis N.J. Olfactory dysfunction in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 2018;5:976&#x2013;981. doi: 10.1002/acn3.594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.594</ArticleId><ArticleId IdType="pmc">PMC6093848</ArticleId><ArticleId IdType="pubmed">30128322</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda M., Watanabe H., Ogura A., Ohdake R., Kato T., Kawabata K., Hara K., Nakamura R., Atsuta N., Epifanio B., et al. Clinicoradiological features in amyotrophic lateral sclerosis patients with olfactory dysfunction. Amyotroph. Lateral Scler. Front. Degener. 2021;22:260&#x2013;266. doi: 10.1080/21678421.2020.1859544.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1859544</ArticleId><ArticleId IdType="pubmed">33908332</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A., Rossi F., Rinaldi F., Compostella S., Cosseddu M., Borroni B., Filosto M., Padovani A. Exploring olfactory function and its relation with behavioral and cognitive impairment in amyotrophic lateral sclerosis patients: A cross-sectional study. Neurodegener. Dis. 2016;16:411&#x2013;416. doi: 10.1159/000446802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000446802</ArticleId><ArticleId IdType="pubmed">27497596</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nther R., Schrempf W., H&#xe4;hner A., Hummel T., Wolz M., Storch A., Hermann A. Impairment in respiratory function contributes to olfactory impairment in amyotrophic lateral sclerosis. Front. Neurol. 2018;9:79. doi: 10.3389/fneur.2018.00079.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00079</ArticleId><ArticleId IdType="pmc">PMC5834512</ArticleId><ArticleId IdType="pubmed">29535673</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang C.J., Schwandner K., Hecht M. Do patients with motor neuron disease suffer from disorders of taste or smell? Amyotroph. Lateral Scler. 2011;12:368&#x2013;371. doi: 10.3109/17482968.2011.579133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.579133</ArticleId><ArticleId IdType="pubmed">21554187</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J., Loewe K., Kaufmann J., Jakubiczka S., Abdulla S., Petri S., Dengler R., Heinze H.-J., Vielhaber S., Schoenfeld M.A., et al. Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology. 2015;85:1301&#x2013;1309. doi: 10.1212/WNL.0000000000002017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002017</ArticleId><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinkhardt E.H., van Elst L.T., Ludolph A.C., Kassubek J. Amygdala size in amyotrophic lateral sclerosis without dementia: An in vivo study using MRI volumetry. BMC Neurol. 2006;6:48. doi: 10.1186/1471-2377-6-48.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-6-48</ArticleId><ArticleId IdType="pmc">PMC1764753</ArticleId><ArticleId IdType="pubmed">17189609</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T., Uchihara T., Kawamura S., Ohashi T. Olfactory dysfunction related to TDP-43 pathology in amyotrophic lateral sclerosis. Clin. Neuropathol. 2014;33:65&#x2013;67. doi: 10.5414/NP300661.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/NP300661</ArticleId><ArticleId IdType="pubmed">24131749</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A., Braak H., Del Tredici K., Lemon R., Ludolph A.C., Kiernan M.C. Cortical influences drive amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2017;88:917&#x2013;924. doi: 10.1136/jnnp-2017-315573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315573</ArticleId><ArticleId IdType="pubmed">28710326</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey N.L., Wesson D.W., Brundin P. The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases. Neurobiol. Dis. 2018;109 Pt B:226&#x2013;248. doi: 10.1016/j.nbd.2016.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.12.013</ArticleId><ArticleId IdType="pmc">PMC5972535</ArticleId><ArticleId IdType="pubmed">28011307</ArticleId></ArticleIdList></Reference><Reference><Citation>Brozzetti L., Sacchetto L., Cecchini M.P., Avesani A., Perra D., Bongianni M., Portioli C., Scupoli M., Ghetti B., Monaco S., et al. Neurodegeneration-associated proteins in human olfactory neurons collected by nasal brushing. Front. Neurosci. 2020;14:145. doi: 10.3389/fnins.2020.00145.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00145</ArticleId><ArticleId IdType="pmc">PMC7066258</ArticleId><ArticleId IdType="pubmed">32194369</ArticleId></ArticleIdList></Reference><Reference><Citation>Lach&#xe9;n-Montes M., Mendizuri N., Ausin K., Andr&#xe9;s-Benito P., Ferrer I., Fern&#xe1;ndez-Irigoyen J., Santamar&#xed;a E. Amyotrophic lateral sclerosis is accompanied by protein derangements in the olfactory bulb-tract axis. Int. J. Mol. Sci. 2020;21:8311. doi: 10.3390/ijms21218311.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21218311</ArticleId><ArticleId IdType="pmc">PMC7664257</ArticleId><ArticleId IdType="pubmed">33167591</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Escudero V., Rosales M., Mu&#xf1;oz J.L., Scola E., Medina J., Khalique H., Garaulet G., Rodriguez A., Lim F. Patient-derived olfactory mucosa for study of the non-neuronal contribution to amyotrophic lateral sclerosis pathology. J. Cell Mol. Med. 2015;19:1284&#x2013;1295. doi: 10.1111/jcmm.12488.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12488</ArticleId><ArticleId IdType="pmc">PMC4459844</ArticleId><ArticleId IdType="pubmed">25807871</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.W., Stifani S. Roles of Runx genes in nervous system development. Adv. Exp. Med. Biol. 2017;962:103&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">28299654</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbach S., Hundt W., Vaitl A., Heinrich P., F&#xf6;rster S., B&#xfc;rger K., Zahnert T. Taste in mild cognitive impairment and Alzheimer&#x2019;s disease. J. Neurol. 2010;257:238&#x2013;246. doi: 10.1007/s00415-009-5300-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5300-6</ArticleId><ArticleId IdType="pubmed">19727902</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah M., Deeb J., Fernando M., Noyce A., Visentin E., Findley L.J., Hawkes C.H. Abnormality of taste and smell in Parkinson&#x2019;s disease. Parkinsonism Relat. Disord. 2009;15:232&#x2013;237. doi: 10.1016/j.parkreldis.2008.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2008.05.008</ArticleId><ArticleId IdType="pubmed">18606556</ArticleId></ArticleIdList></Reference><Reference><Citation>Heckmann J.G., St&#xf6;ssel C., Lang C.J., Neund&#xf6;rfer B., Tomandl B., Hummel T. Taste disorders in acute stroke: A prospective observational study on taste disorders in 102 stroke patients. Stroke. 2005;36:1690&#x2013;1694. doi: 10.1161/01.STR.0000173174.79773.d3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000173174.79773.d3</ArticleId><ArticleId IdType="pubmed">16002758</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.S., Choi-Kwon S., Kwon S.U., Kwon J.H. Taste perception abnormalities after acute stroke in postmenopausal women. J. Clin. Neurosci. 2009;16:797&#x2013;801. doi: 10.1016/j.jocn.2008.08.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2008.08.038</ArticleId><ArticleId IdType="pubmed">19297163</ArticleId></ArticleIdList></Reference><Reference><Citation>Scinska A., Sienkiewicz-Jarosz H., Kuran W., Ryglewicz D., Rogowski A., Wrobel E., Korkosz A., Kukwa A., Kostowski W., Bienkowski P. Depressive symptoms and taste reactivity in humans. Physiol. Behav. 2004;82:899&#x2013;904. doi: 10.1016/S0031-9384(04)00315-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0031-9384(04)00315-4</ArticleId><ArticleId IdType="pubmed">15451656</ArticleId></ArticleIdList></Reference><Reference><Citation>Imoscopi A., Inelmen E.M., Sergi G., Miotto F., Manzato E. Taste loss in the elderly: Epidemiology, causes and consequences. Aging Clin. Exp. Res. 2012;24:570&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">22828477</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarlarini C., Greco L.C., Lizio A., Gerardi F., Sansone V.A., Lunetta C. Taste changes in amyotrophic lateral sclerosis and effects on quality of life. Neurol. Sci. 2019;40:399&#x2013;404. doi: 10.1007/s10072-018-3672-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-018-3672-z</ArticleId><ArticleId IdType="pubmed">30515604</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashary A.A., Patel D.N., Hirsch A.R. 101 Amyotrophic lateral sclerosis (ALS)&#x2014;Not just a motor disease? Isolated bitter and sweet taste loss in ALS. CNS Spectr. 2020;25:266. doi: 10.1017/S109285292000019X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S109285292000019X</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishihira Y., Tan C.-F., Onodera O., Toyoshima Y., Yamada M., Morita T., Nishizawa M., Kakita A., Takahashi H. Sporadic amyotrophic lateral sclerosis: Two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol. 2008;116:169&#x2013;182. doi: 10.1007/s00401-008-0385-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0385-z</ArticleId><ArticleId IdType="pubmed">18481073</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateishi T., Hokonohara T., Yamasaki R., Miura S., Kikuchi H., Iwaki A., Tashiro H., Furuya H., Nagara Y., Ohyagi Y., et al. Multiple system degeneration with basophilic inclusions in Japanese ALS patients with FUS mutation. Acta Neuropathol. 2010;119:355&#x2013;364. doi: 10.1007/s00401-009-0621-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-009-0621-1</ArticleId><ArticleId IdType="pubmed">19967541</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohashi N., Nonami J., Kodaira M., Yoshida K., Sekijima Y. Taste disorder in facial onset sensory and motor neuronopathy: A case report. BMC Neurol. 2020;20:71. doi: 10.1186/s12883-020-01639-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-020-01639-x</ArticleId><ArticleId IdType="pmc">PMC7049225</ArticleId><ArticleId IdType="pubmed">32113480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonoda K., Sasaki K., Tateishi T., Yamasaki R., Hayashi S., Sakae N., Ohyagi Y., Iwaki T., Kira J.-I. TAR DNA-binding protein 43 pathology in a case clinically diagnosed with facial-onset sensory and motor neuronopathy syndrome: An autopsied case report and a review of the literature. J. Neurol. Sci. 2013;332:148&#x2013;153. doi: 10.1016/j.jns.2013.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2013.06.027</ArticleId><ArticleId IdType="pubmed">23849263</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziso B., Williams T.L., Walters R.J., Jaiser S.R., Attems J., Wieshmann U.C., Larner A.J., Jacob A. Facial onset sensory and motor neuronopathy: Further evidence for a TDP-43 proteinopathy. Case Rep. Neurol. 2015;7:95&#x2013;100. doi: 10.1159/000381944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000381944</ArticleId><ArticleId IdType="pmc">PMC4448067</ArticleId><ArticleId IdType="pubmed">26327906</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossor A.M., Jaunmuktane Z., Rossor M.N., Hoti G., Reilly M.M. TDP43 pathology in the brain, spinal cord, and dorsal root ganglia of a patient with FOSMN. Neurology. 2019;92:e951&#x2013;e956. Correction in Neurology 2019, 93, e88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6404468</ArticleId><ArticleId IdType="pubmed">30700593</ArticleId></ArticleIdList></Reference><Reference><Citation>Low P.A., Ahlskog J.E., Petersen R.C., Waring S.C., Esteban-Santillan C., Kurland L.T. Autonomic failure in Guamanian neurodegenerative disease. Neurology. 1997;49:1031&#x2013;1034. doi: 10.1212/WNL.49.4.1031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.49.4.1031</ArticleId><ArticleId IdType="pubmed">9339685</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccione E.A., Sletten D.M., Staff N.P., Low P.A. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015;51:676&#x2013;679. doi: 10.1002/mus.24457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.24457</ArticleId><ArticleId IdType="pmc">PMC4362936</ArticleId><ArticleId IdType="pubmed">25211238</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Hayashi H., Kato S., Hayashi M., Tanabe H., Oda M. Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J. Neurol. Sci. 1994;124:45&#x2013;55. doi: 10.1016/0022-510X(94)90009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90009-4</ArticleId><ArticleId IdType="pubmed">7931421</ArticleId></ArticleIdList></Reference><Reference><Citation>Baltadzhieva R., Gurevich T., Korczyn A.D. Autonomic impairment in amyotrophic lateral sclerosis. Curr. Opin. Neurol. 2005;18:487&#x2013;493. doi: 10.1097/01.wco.0000183114.76056.0e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000183114.76056.0e</ArticleId><ArticleId IdType="pubmed">16155429</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel R., Ferreira C., Valenti V., Garner D., Macedo H., Oliveira A., Leit&#xe3;o F., de Abreu L. Complexity measures of heart-rate variability in amyotrophic lateral sclerosis with alternative pulmonary capacities. Entropy. 2021;23:159. doi: 10.3390/e23020159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/e23020159</ArticleId><ArticleId IdType="pmc">PMC7911551</ArticleId><ArticleId IdType="pubmed">33525566</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimentel R.M.M., Macedo H., Valenti V., Rocha F.O., de Abreu L.C., Monteiro C.B.D.M., Ferreira C. Decreased heart rate variability in individuals with amyotrophic lateral sclerosis. Respir. Care. 2019;64:1088&#x2013;1095. doi: 10.4187/respcare.06681.</Citation><ArticleIdList><ArticleId IdType="doi">10.4187/respcare.06681</ArticleId><ArticleId IdType="pubmed">31138737</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachs C., Conradi S., Kaijser L. Autonomic function in amyotrophic lateral sclerosis: A study of cardiovascular responses. Acta Neurol. Scand. 1985;71:373&#x2013;378. doi: 10.1111/j.1600-0404.1985.tb03215.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1985.tb03215.x</ArticleId><ArticleId IdType="pubmed">4013661</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandinov B., Korczyn A.D., Rabinowitz R., Nefussy B., Drory V.E. Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis. Auton. Neurosci. 2011;159:84&#x2013;89. doi: 10.1016/j.autneu.2010.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2010.09.002</ArticleId><ArticleId IdType="pubmed">20869331</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandinov B., Drory V.E., Tordjman K., Korczyn A.D. Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2012;13:509&#x2013;513. doi: 10.3109/17482968.2012.662986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2012.662986</ArticleId><ArticleId IdType="pubmed">22424128</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Yamada M., Koumura A., Sakurai T., Hayashi Y., Kimura A., Hozumi I., Inuzuka T. Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: Analysis using cardiac [123I] MIBG scintigraphy. J. Neurol. 2013;260:2380&#x2013;2386. doi: 10.1007/s00415-013-7005-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-013-7005-0</ArticleId><ArticleId IdType="pubmed">23784610</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M., Flachenecker P., Magnus T., Giess R., Reiners K., Toyka K.V., Naumann M. Autonomic dysfunction in ALS: A preliminary study on the effects of intrathecal BDNF. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2005;6:100&#x2013;103. doi: 10.1080/14660820510028412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510028412</ArticleId><ArticleId IdType="pubmed">16036433</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchia L.D., De Maria B., Marinou K., Sideri R., Lucini A., Porta A., Mora G. Cardiovascular neural regulation is impaired in amyotrophic lateral sclerosis patients. A study by spectral and complexity analysis of cardiovascular oscillations. Physiol. Meas. 2015;36:659&#x2013;670. doi: 10.1088/0967-3334/36/4/659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1088/0967-3334/36/4/659</ArticleId><ArticleId IdType="pubmed">25798998</ArticleId></ArticleIdList></Reference><Reference><Citation>Tutaj M., Miller M., Tomik B., Golenia A., Stanuszek A., B&#x141;o&#x144;ska K., S&#x141;owik A. Sympathetic vascular response to facial cooling is increased in flail phenotypes of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2018;19:29&#x2013;37. doi: 10.1080/21678421.2017.1380672.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1380672</ArticleId><ArticleId IdType="pubmed">28980485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Kato S., Hayashi M., Hayashi H., Tanabe H. Amyotrophic lateral sclerosis with hypertensive attacks: Blood pressure changes in response to drug administration. Clin. Auton. Res. 1996;6:241&#x2013;244. doi: 10.1007/BF02291141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02291141</ArticleId><ArticleId IdType="pubmed">8902322</ArticleId></ArticleIdList></Reference><Reference><Citation>Asai H., Hirano M., Udaka F., Shimada K., Oda M., Kubori T., Nishinaka K., Tsujimura T., Izumi Y., Konishi N., et al. Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALS. J. Neurol. Sci. 2007;254:78&#x2013;83. doi: 10.1016/j.jns.2007.01.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.01.007</ArticleId><ArticleId IdType="pubmed">17303172</ArticleId></ArticleIdList></Reference><Reference><Citation>Drusehky A., Spitzer A., Platseh G., Claus D., Feistel H., Druschky K., Hilz M.-J., Neund&#xf6;rfer B. Cardiac sympathetic denervation in early stages of amyotrophic lateral sclerosis demonstrated by 123I-MIBG-SPECT. Acta Neurol. Scand. 1999;99:308&#x2013;314. doi: 10.1111/j.1600-0404.1999.tb00681.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1999.tb00681.x</ArticleId><ArticleId IdType="pubmed">10348161</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsborg M., Andersen E.B., Wiinberg N., Gredal O., J&#xf8;rgensen L., Mehlsen J. Sympathetic dysfunction of central origin in patients with ALS. Eur. J. Neurol. 2003;10:229&#x2013;234. doi: 10.1046/j.1468-1331.2003.00578.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.2003.00578.x</ArticleId><ArticleId IdType="pubmed">12752395</ArticleId></ArticleIdList></Reference><Reference><Citation>Provinciali L., Cangiotti A., Tulli D., Carboni V., Cinti S. Skin abnormalities and autonomic involvement in the early stage of amyotrophic lateral sclerosis. J. Neurol. Sci. 1994;126:54&#x2013;61. doi: 10.1016/0022-510X(94)90094-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90094-9</ArticleId><ArticleId IdType="pubmed">7836947</ArticleId></ArticleIdList></Reference><Reference><Citation>Oey P.L., Vos P.E., Wieneke G.H., Wokke J.H., Blankestijn P.J., Karemaker J.M. Subtle involvement of the sympathetic nervous system in amyotrophic lateral sclerosis. Muscle Nerve. 2002;25:402&#x2013;408. doi: 10.1002/mus.10049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10049</ArticleId><ArticleId IdType="pubmed">11870718</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavlovic S., Stevic Z., Milovanovic B., Milicic B., Rakocevic-Stojanovic V., Lavrnic D., Apostolski S. Impairment of cardiac autonomic control in patients with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2010;11:272&#x2013;276. doi: 10.3109/17482960903390855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903390855</ArticleId><ArticleId IdType="pubmed">20001491</ArticleId></ArticleIdList></Reference><Reference><Citation>Merico A., Cavinato M. Autonomic dysfunction in the early stage of ALS with bulbar involvement. Amyotroph. Lateral Scler. 2011;12:363&#x2013;367. doi: 10.3109/17482968.2011.584628.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.584628</ArticleId><ArticleId IdType="pubmed">21623664</ArticleId></ArticleIdList></Reference><Reference><Citation>De Maria B., Bari V., Marchi A., Barbic F., Furlan R., Mora G., Dalla Vecchia L., Porta A. Cardiovascular control indexes in amyotrophic lateral sclerosis patients and their relation with clinical markers; Proceedings of the 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC); Milan, Italy. 25&#x2013;29 August 2015; pp. 2055&#x2013;2058.</Citation><ArticleIdList><ArticleId IdType="pubmed">26736691</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisano F., Miscio G., Mazzuero G., Lanfranchi P., Colombo R., Pinelli P. Decreased heart rate variability in amyotrophic lateral sclerosis. Muscle Nerve. 1995;18:1225&#x2013;1231. doi: 10.1002/mus.880181103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880181103</ArticleId><ArticleId IdType="pubmed">7565918</ArticleId></ArticleIdList></Reference><Reference><Citation>Linden D., Diehl R.R., Berlit P. Reduced baroreflex sensitivity and cardiorespiratory transfer in amyotrophic lateral sclerosis. Electroencephalogr. Clin. Neurophysiol. 1998;109:387&#x2013;390. doi: 10.1016/S0924-980X(98)00035-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0924-980X(98)00035-6</ArticleId><ArticleId IdType="pubmed">9851294</ArticleId></ArticleIdList></Reference><Reference><Citation>Congiu P., Mariani S., Milioli G., Parrino L., Tamburrino L., Borghero G., Defazio G., Pereira B., Fantini M.L., Puligheddu M. Sleep cardiac dysautonomia and EEG oscillations in amyotrophic lateral sclerosis. Sleep. 2019;42:zsz164. doi: 10.1093/sleep/zsz164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/zsz164</ArticleId><ArticleId IdType="pubmed">31312838</ArticleId></ArticleIdList></Reference><Reference><Citation>Donadio V., Liguori R. Microneurographic recording from unmyelinated nerve fibers in neurological disorders: An update. Clin. Neurophysiol. 2015;126:437&#x2013;445. doi: 10.1016/j.clinph.2014.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.10.009</ArticleId><ArticleId IdType="pubmed">25457652</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo K. [Sympathetic neurograms in patients with neurodegenerative disorders&#x2014;An overview] Brain Nerve. 2009;61:263&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">19301596</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck M., Giess R., Magnus T., Puls I., Reiners K., Toyka K.V., Naumann M. Progressive sudomotor dysfunction in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2002;73:68&#x2013;70. doi: 10.1136/jnnp.73.1.68.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.73.1.68</ArticleId><ArticleId IdType="pmc">PMC1757317</ArticleId><ArticleId IdType="pubmed">12082050</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos-Bento M., de Carvalho M., Evangelista T., Sales Lu&#xed;s M.L. Sympathetic sudomotor function and amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2001;2:105&#x2013;108. doi: 10.1080/146608201316949550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608201316949550</ArticleId><ArticleId IdType="pubmed">11675871</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo K., Tsunoda S., Shiozawa Z. Increased sympathetic outflow to muscles in patients with amyotrophic lateral sclerosis: A comparison with other neuromuscular patients. J. Neurol. Sci. 1995;134:57&#x2013;60. doi: 10.1016/0022-510X(95)00189-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(95)00189-4</ArticleId><ArticleId IdType="pubmed">8747844</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo K., Watanabe H., Ohta E., Nagasaka T., Shiozawa Z., Takiyama Y. Sympathetic sudomotor neural function in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011;12:39&#x2013;44. doi: 10.3109/17482968.2010.508529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2010.508529</ArticleId><ArticleId IdType="pubmed">20735281</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F., Jin J., Qu Q., Dang J. Sympathetic skin response in amyotrophic lateral sclerosis. J. Clin. Neurophysiol. 2016;33:60&#x2013;65. doi: 10.1097/WNP.0000000000000226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNP.0000000000000226</ArticleId><ArticleId IdType="pubmed">26844971</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettmers C., Fatepour D., Faust H., Jerusalem F. Sympathetic skin response abnormalities in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:930&#x2013;934. doi: 10.1002/mus.880160907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880160907</ArticleId><ArticleId IdType="pubmed">8355724</ArticleId></ArticleIdList></Reference><Reference><Citation>Barron S.A., Mazliah J., Bental E. Sympathetic cholinergic dysfunction in amyotrophic lateral sclerosis. Acta Neurol. Scand. 1987;75:62&#x2013;63. doi: 10.1111/j.1600-0404.1987.tb07890.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1987.tb07890.x</ArticleId><ArticleId IdType="pubmed">3577669</ArticleId></ArticleIdList></Reference><Reference><Citation>Masur H., Schulte-Oversohl U., Papke K., Oberwittler C., Vollmer J. Sympathetic skin response in patients with amyotrophic lateral sclerosis. Funct. Neurol. 1995;10:131&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">8557214</ArticleId></ArticleIdList></Reference><Reference><Citation>Miscio G., Pisano F. Sympathetic skin response in amyotrophic lateral sclerosis. Acta Neurol. Scand. 1998;98:276&#x2013;279. doi: 10.1111/j.1600-0404.1998.tb07308.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1998.tb07308.x</ArticleId><ArticleId IdType="pubmed">9808278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kihara M., Takahashi A., Sugenoya J., Kihara Y., Watanabe H. Sudomotor dysfunction in amyotrophic lateral sclerosis. Funct. Neurol. 1994;9:193&#x2013;197.</Citation><ArticleIdList><ArticleId IdType="pubmed">7883205</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindo K., Shimokawa C., Watanabe H., Iida H., Ohashi K., Nitta K., Nagasaka T., Tsunoda S., Shiozawa Z. Chronological changes of sympathetic outflow to muscles in amyotrophic lateral sclerosis. J. Neurol. Sci. 2004;227:79&#x2013;84. doi: 10.1016/j.jns.2004.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2004.08.006</ArticleId><ArticleId IdType="pubmed">15546595</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T., Iijima M., Shimizu Y., Yoshizawa H., Miyashiro M., Onizuka H., Yamamoto T., Nishiyama A., Suzuki N., Aoki M., et al. p.N345K mutation in TARDBP in a patient with familial amyotrophic lateral sclerosis: An autopsy case. Neuropathology. 2019;39:286&#x2013;293. doi: 10.1111/neup.12559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12559</ArticleId><ArticleId IdType="pubmed">31124595</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfc;bling G.S., Mie E., Bauer R.M., Hensler M., Lorenzl S., Hapfelmeier A., Irwin D.E., Borasio G.D., Winkler A.S. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2014;15:174&#x2013;179. doi: 10.3109/21678421.2013.868001.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.868001</ArticleId><ArticleId IdType="pubmed">24479577</ArticleId></ArticleIdList></Reference><Reference><Citation>Charchaflie R.J., Bustos Fernandez L., Perec C.J., Gonzalez E., Marzi A. Functional studies of the parotid and pancreas glands in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 1974;37:863&#x2013;867. doi: 10.1136/jnnp.37.7.863.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.37.7.863</ArticleId><ArticleId IdType="pmc">PMC494795</ArticleId><ArticleId IdType="pubmed">4852110</ArticleId></ArticleIdList></Reference><Reference><Citation>Giess R., Werner E., Beck M., Reiners C., Toyka K.V., Naumann M. Impaired salivary gland function reveals autonomic dysfunction in amyotrophic lateral sclerosis. J. Neurol. 2002;249:1246&#x2013;1249. doi: 10.1007/s00415-002-0820-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-002-0820-3</ArticleId><ArticleId IdType="pubmed">12242548</ArticleId></ArticleIdList></Reference><Reference><Citation>Copperman R. Letter: Decreased lacrimation in amyotrophic lateral sclerosis. JAMA. 1974;230:536. doi: 10.1001/jama.1974.03240040014005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.1974.03240040014005</ArticleId><ArticleId IdType="pubmed">4479168</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M., Folwaczny C., Klauser A., Riepl R.L., M&#xfc;ller-Felber W., Pongratz D. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 1999;1:15&#x2013;19. doi: 10.1080/146608299300079484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608299300079484</ArticleId><ArticleId IdType="pubmed">12365061</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M., Folwaczny C., Lochm&#xfc;ller H., Schroeder M., Riepl R., Pongratz D., M&#xfc;ller-Felber W. Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion. 1999;60:567&#x2013;571. doi: 10.1159/000007708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000007708</ArticleId><ArticleId IdType="pubmed">10545728</ArticleId></ArticleIdList></Reference><Reference><Citation>Toepfer M., Schroeder M., Klauser A., Lochm&#xfc;ller H., Hirschmann M., Riepl R.L., Pongratz D., M&#xfc;ller-Felber W. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur. J. Med. Res. 1997;2:473&#x2013;476.</Citation><ArticleIdList><ArticleId IdType="pubmed">9385117</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith A.w., Mulder D.w., Code C.f. Esophageal motility in amyotrophic lateral sclerosis. Proc. Staff Meet Mayo Clin. 1957;32:438&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">13465823</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada T., Itoh K., Matsuo K., Yamamoto Y., Hosokawa Y., Koizumi T., Shiga K., Mizuno T., Nakagawa M., Fushiki S. Concomitant alpha-synuclein pathology in an autopsy case of amyotrophic lateral sclerosis presenting with orthostatic hypotension and cardiac arrests. Neuropathology. 2014;34:164&#x2013;169. doi: 10.1111/neup.12057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12057</ArticleId><ArticleId IdType="pubmed">23898972</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogucki A., Salvesen R. Sympathetic iris function in amyotrophic lateral sclerosis. J. Neurol. 1987;234:185&#x2013;186. doi: 10.1007/BF00314141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00314141</ArticleId><ArticleId IdType="pubmed">3585428</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohno T., Shimizu T., Kato S., Hayashi H., Hirai S. Effect of tamsulosin hydrochloride on sympathetic hyperactivity in amyotrophic lateral sclerosis. Auton. Neurosci. 2001;88:94&#x2013;98. doi: 10.1016/S1566-0702(01)00217-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1566-0702(01)00217-X</ArticleId><ArticleId IdType="pubmed">11474551</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Hoshide S., Kario K. The insular cortex and cardiovascular system: A new insight into the brain-heart axis. J. Am. Soc. Hypertens. 2010;4:174&#x2013;182. doi: 10.1016/j.jash.2010.05.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jash.2010.05.001</ArticleId><ArticleId IdType="pubmed">20655502</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H., Kato S. Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state. J. Neurol. Sci. 1989;93:19&#x2013;35. doi: 10.1016/0022-510X(89)90158-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(89)90158-5</ArticleId><ArticleId IdType="pubmed">2809628</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato S., Oda M., Tanabe H. Diminution of dopaminergic neurons in the substantia nigra of sporadic amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 1993;19:300&#x2013;304. doi: 10.1111/j.1365-2990.1993.tb00444.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1993.tb00444.x</ArticleId><ArticleId IdType="pubmed">7901781</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Kawata A., Kato S., Hayashi M., Takamoto K., Hirai S., Yamaguchi S., Komori T., Oda M. Autonomic failure in ALS with a novel SOD1 gene mutation. Neurology. 2000;54:1534&#x2013;1537. doi: 10.1212/WNL.54.7.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.54.7.1534</ArticleId><ArticleId IdType="pubmed">10751275</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K., Mochizuki Y., Koide R., Kawata A., Homma T., Shimizu T., Komori T., Isozaki E. A Japanese familial ALS patient with autonomic failure and a p.Cys146Arg mutation in the gene for SOD1 (SOD1) Neuropathology. 2016;36:551&#x2013;555. doi: 10.1111/neup.12303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12303</ArticleId><ArticleId IdType="pubmed">27090969</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu T., Hayashi M., Kawata A., Mizutani T., Watabe K., Matsubara S. A morphometric study of the vagus nerve in amyotropic lateral sclerosis with circulatory collapse. Amyotroph. Lateral Scler. 2011;12:356&#x2013;362. doi: 10.3109/17482968.2011.566342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.566342</ArticleId><ArticleId IdType="pubmed">21434813</ArticleId></ArticleIdList></Reference><Reference><Citation>Konno H., Yamamoto T., Iwasaki Y., Iizuka H. Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J. Neurol. Sci. 1986;73:193&#x2013;204. doi: 10.1016/0022-510X(86)90130-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(86)90130-9</ArticleId><ArticleId IdType="pubmed">3701375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy P.G., Duchen L.W. A quantitative study of intermediolateral column cells in motor neuron disease and the Shy-Drager syndrome. J. Neurol. Neurosurg. Psychiatry. 1985;48:1103&#x2013;1106. doi: 10.1136/jnnp.48.11.1103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.48.11.1103</ArticleId><ArticleId IdType="pmc">PMC1028568</ArticleId><ArticleId IdType="pubmed">4078575</ArticleId></ArticleIdList></Reference><Reference><Citation>Itoh T., Sobue G., Ken E., Mitsuma T., Takahashi A., Trojanowski J.Q. Phosphorylated high molecular weight neurofilament protein in the peripheral motor, sensory and sympathetic neuronal perikarya: System-dependent normal variations and changes in amyotrophic lateral sclerosis and multiple system atrophy. Acta Neuropathol. 1992;83:240&#x2013;245. doi: 10.1007/BF00296785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00296785</ArticleId><ArticleId IdType="pubmed">1557955</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi H., Oyanagi K., Ikuta F. The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis. Acta Neuropathol. 1993;86:190&#x2013;192. doi: 10.1007/BF00334889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00334889</ArticleId><ArticleId IdType="pubmed">8213074</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandinov B., Grigoriadis N.C., Touloumi O., Drory V.E., Offen D., Korczyn A.D. Immunohistochemical analysis of sympathetic involvement in the SOD1-G93A transgenic mouse model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:424&#x2013;433. doi: 10.3109/21678421.2013.780622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.780622</ArticleId><ArticleId IdType="pubmed">23607704</ArticleId></ArticleIdList></Reference><Reference><Citation>Pullen A.H., Martin J.E. Ultrastructural abnormalities with inclusions in Onuf&#x2019;s nucleus in motor neuron disease (amyotrophic lateral sclerosis) Neuropathol. Appl. Neurobiol. 1995;21:327&#x2013;340. doi: 10.1111/j.1365-2990.1995.tb01067.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2990.1995.tb01067.x</ArticleId><ArticleId IdType="pubmed">7494601</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho M., Schwartz M.S., Swash M. Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve. 1995;18:848&#x2013;853. doi: 10.1002/mus.880180808.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880180808</ArticleId><ArticleId IdType="pubmed">7630345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S., Maruyama S. A fine structural study of Onuf&#x2019;s nucleus in sporadic amyotrophic lateral sclerosis. J. Neurol. Sci. 1993;119:28&#x2013;37. doi: 10.1016/0022-510X(93)90188-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(93)90188-5</ArticleId><ArticleId IdType="pubmed">8246008</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzano R., Sorar&#xfa; G., Grunseich C., Fratta P., Zuccaro E., Pennuto M., Rinaldi C. Beyond motor neurons: Expanding the clinical spectrum in Kennedy&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 2018;89:808&#x2013;812. doi: 10.1136/jnnp-2017-316961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-316961</ArticleId><ArticleId IdType="pmc">PMC6204939</ArticleId><ArticleId IdType="pubmed">29353237</ArticleId></ArticleIdList></Reference><Reference><Citation>Powis R.A., Gillingwater T.H. Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy. J. Anat. 2016;228:443&#x2013;451. doi: 10.1111/joa.12419.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joa.12419</ArticleId><ArticleId IdType="pmc">PMC5341542</ArticleId><ArticleId IdType="pubmed">26576026</ArticleId></ArticleIdList></Reference><Reference><Citation>Anneser J.M., Borasio G.D., Berthele A., Zieglg&#xe4;nsberger W., T&#xf6;lle T.R. Differential expression of group I metabotropic glutamate receptors in rat spinal cord somatic and autonomic motoneurons: Possible implications for the pathogenesis of amyotrophic lateral sclerosis. Neurobiol. Dis. 1999;6:140&#x2013;147. doi: 10.1006/nbdi.1999.0237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.1999.0237</ArticleId><ArticleId IdType="pubmed">10343329</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney E.B., de Winter F., Verhaagen J. ALS as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front. Neurosci. 2014;8:252. doi: 10.3389/fnins.2014.00252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pmc">PMC4132373</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465. doi: 10.1038/ncomms10465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R., Liu Y., Yang L., Gal J., Zhu H., Jia J. Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a Drosophila model of Fus-mediated ALS. Mol. Neurodegener. 2012;7:10. doi: 10.1186/1750-1326-7-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-10</ArticleId><ArticleId IdType="pmc">PMC3325858</ArticleId><ArticleId IdType="pubmed">22443542</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Li Y., Asress S.A., Jones D.P., Glass J.D. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp. Neurol. 2012;233:163&#x2013;171. doi: 10.1016/j.expneurol.2011.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.09.020</ArticleId><ArticleId IdType="pmc">PMC4068963</ArticleId><ArticleId IdType="pubmed">21963651</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokic N., De Aguilar J.-L.G., Dimou L., Lin S., Fergani A., Ruegg M.A., Schwab M.E., Dupuis L., Loeffler J.-P. The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model. EMBO Rep. 2006;7:1162&#x2013;1167. doi: 10.1038/sj.embor.7400826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.embor.7400826</ArticleId><ArticleId IdType="pmc">PMC1679784</ArticleId><ArticleId IdType="pubmed">17039253</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng F.Y., Tang B.L. Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis. J. Cell Mol. Med. 2008;12:1199&#x2013;1204. doi: 10.1111/j.1582-4934.2008.00351.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2008.00351.x</ArticleId><ArticleId IdType="pmc">PMC3865663</ArticleId><ArticleId IdType="pubmed">18419791</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S., Mansfield C., Jimenez-Moreno R., Del Gaizo Moore V., Yoshikawa M., Hampton T.G., Prevette D., Caress J., Oppenheim R.W., Milligan C. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: Part I, background and methods. Brain Behav. 2013;3:335&#x2013;350. doi: 10.1002/brb3.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.143</ArticleId><ArticleId IdType="pmc">PMC3869677</ArticleId><ArticleId IdType="pubmed">24381807</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S., Mansfield C., Jimenez-Moreno R., Del Gaizo Moore V., Yoshikawa M., Hampton T.G., Prevette D., Caress J., Oppenheim R.W., Milligan C. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: Part II, results and discussion. Brain Behav. 2013;3:431&#x2013;457. doi: 10.1002/brb3.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.142</ArticleId><ArticleId IdType="pmc">PMC3869683</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Bauch&#xe9; S., de Aguilar J.L.G., Brochier G., Mandjee N., Tanguy M.-L., Hussain G., Behin A., Khiami F., Sariali E., et al. Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann. Clin. Transl. Neurol. 2015;2:362&#x2013;372. doi: 10.1002/acn3.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter F., Vo T., Stam F.J., Wisman L.A., B&#xe4;r P.R., Niclou S., van Muiswinkel F.L., Verhaagen J. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol. Cell Neurosci. 2006;32:102&#x2013;117. doi: 10.1016/j.mcn.2006.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2006.03.002</ArticleId><ArticleId IdType="pubmed">16677822</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanara P., Banerjee J., Hueck R.V., Harper M.R., Awada M., Turner H., Husted K.H., Brandt R., Hellerstein M.K. Stabilization of hyperdynamic microtubules is neuroprotective in amyotrophic lateral sclerosis. J. Biol. Chem. 2007;282:23465&#x2013;23472. doi: 10.1074/jbc.M703434200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M703434200</ArticleId><ArticleId IdType="pubmed">17567579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland L.G., Sahai E., Kelly G., Golding M., Greensmith L., Schiavo G. Deficits in axonal transport precede ALS symptoms in vivo. Proc. Natl. Acad. Sci. USA. 2010;107:20523&#x2013;20528. doi: 10.1073/pnas.1006869107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006869107</ArticleId><ArticleId IdType="pmc">PMC2996651</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinkovic P., Reuter M.S., Brill M.S., Godinho L., Kerschensteiner M., Misgeld T. Axonal transport deficits and degeneration can evolve independently in mouse models of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2012;109:4296&#x2013;4301. doi: 10.1073/pnas.1200658109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1200658109</ArticleId><ArticleId IdType="pmc">PMC3306689</ArticleId><ArticleId IdType="pubmed">22371592</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson T.L., Cleveland D.W. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat. Neurosci. 1999;2:50&#x2013;56. doi: 10.1038/4553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4553</ArticleId><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathis S., Goizet C., Soulages A., Vallat J.M., Masson G.L. Genetics of amyotrophic lateral sclerosis: A review. J. Neurol. Sci. 2019;399:217&#x2013;226. doi: 10.1016/j.jns.2019.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.02.030</ArticleId><ArticleId IdType="pubmed">30870681</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki N., Akiyama T., Warita H., Aoki M. Omics approach to axonal dysfunction of motor neurons in amyotrophic lateral sclerosis (ALS) Front. Neurosci. 2020;14:194. doi: 10.3389/fnins.2020.00194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00194</ArticleId><ArticleId IdType="pmc">PMC7109447</ArticleId><ArticleId IdType="pubmed">32269505</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini G.A., Burns M., Binder L.I., Kanaan N.M., Lapointe N., Bosco D.A., Brown R.H., Jr., Brown H., Tiwari A., Hayward L., et al. Axonal transport defects in neurodegenerative diseases. J. Neurosci. 2009;29:12776&#x2013;12786. doi: 10.1523/JNEUROSCI.3463-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3463-09.2009</ArticleId><ArticleId IdType="pmc">PMC2801051</ArticleId><ArticleId IdType="pubmed">19828789</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D., Rusmini P., Crippa V., Onesto E., Bolzoni E., Ratti A., Poletti A. Dysregulation of axonal transport and motorneuron diseases. Biol. Cell. 2011;103:87&#x2013;107. doi: 10.1042/BC20100093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BC20100093</ArticleId><ArticleId IdType="pubmed">21250942</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellanos-Montiel M.J., Chaineau M., Durcan T.M. The neglected genes of ALS: Cytoskeletal dynamics impact synaptic degeneration in ALS. Front. Cell Neurosci. 2020;14:594975. doi: 10.3389/fncel.2020.594975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.594975</ArticleId><ArticleId IdType="pmc">PMC7691654</ArticleId><ArticleId IdType="pubmed">33281562</ArticleId></ArticleIdList></Reference><Reference><Citation>Spaulding E.L., Burgess R.W. Accumulating evidence for axonal translation in neuronal homeostasis. Front. Neurosci. 2017;11:312. doi: 10.3389/fnins.2017.00312.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00312</ArticleId><ArticleId IdType="pmc">PMC5450000</ArticleId><ArticleId IdType="pubmed">28620277</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagano S., Jinno J., Abdelhamid R.F., Jin Y., Shibata M., Watanabe S., Hirokawa S., Nishizawa M., Sakimura K., Onodera O., et al. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons. Acta Neuropathol. 2020;140:695&#x2013;713. doi: 10.1007/s00401-020-02205-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02205-y</ArticleId><ArticleId IdType="pubmed">32803350</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Glass J.D. Axonal degeneration in motor neuron disease. Neurodegener. Dis. 2007;4:431&#x2013;442. doi: 10.1159/000107704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000107704</ArticleId><ArticleId IdType="pubmed">17934327</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller F., Song W., Jang Y.C., Liu Y., Sabia M., Richardson A., Van Remmen H. Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007;293:R1159&#x2013;R1168. doi: 10.1152/ajpregu.00767.2006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00767.2006</ArticleId><ArticleId IdType="pubmed">17584954</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller F.L., Song W., Liu Y., Chaudhuri A., Pieke-Dahl S., Strong R., Huang T.-T., Epstein C.J., Roberts L.J., Csete M., et al. Absence of CuZn superoxide dismutase leads to elevated oxidative stress and acceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 2006;40:1993&#x2013;2004. doi: 10.1016/j.freeradbiomed.2006.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2006.01.036</ArticleId><ArticleId IdType="pubmed">16716900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunton-Stasyshyn R.K., Saccon R.A., Fratta P., Fisher E.M. SOD1 function and its implications for amyotrophic lateral sclerosis pathology: New and renascent themes. Neuroscientist. 2015;21:519&#x2013;529. doi: 10.1177/1073858414561795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073858414561795</ArticleId><ArticleId IdType="pubmed">25492944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 2009;187:761&#x2013;772. doi: 10.1083/jcb.200908164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200908164</ArticleId><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon R.A., Bunton-Stasyshyn R.K., Fisher E.M., Fratta P. Is SOD1 loss of function involved in amyotrophic lateral sclerosis? Pt 8Brain. 2013;136:2342&#x2013;2358. doi: 10.1093/brain/awt097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt097</ArticleId><ArticleId IdType="pmc">PMC3722346</ArticleId><ArticleId IdType="pubmed">23687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Sau D., De Biasi S., Vitellaro-Zuccarello L., Riso P., Guarnieri S., Porrini M., Simeoni S., Crippa V., Onesto E., Palazzolo I., et al. Mutation of SOD1 in ALS: A gain of a loss of function. Hum. Mol. Genet. 2007;16:1604&#x2013;1618. doi: 10.1093/hmg/ddm110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm110</ArticleId><ArticleId IdType="pubmed">17504823</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi E.E., Bergh J., Zetterstr&#xf6;m P., Forsberg K., Pakkenberg B., Andersen P.M., Marklund S.L., Br&#xe4;nnstr&#xf6;m T. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 2018;136:939&#x2013;953. doi: 10.1007/s00401-018-1915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T., Cudkowicz M., Shaw P.J., Andersen P.M., Atassi N., Bucelli R.C., Genge A., Glass J., Ladha S., Ludolph A.L., et al. Phase 1&#x2013;2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003;300:808&#x2013;812. doi: 10.1126/science.1083129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083129</ArticleId><ArticleId IdType="pubmed">12730604</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D., Hafezparast M., Bohnert S., Dick J.R.T., Martin J., Schiavo G., Fisher E., Greensmith L. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 2005;169:561&#x2013;567. doi: 10.1083/jcb.200501085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200501085</ArticleId><ArticleId IdType="pmc">PMC2171702</ArticleId><ArticleId IdType="pubmed">15911875</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>